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Actin plays a crucial role in cellular processes ranging from the maintenance of cell 
structure, motility, signal transduction, and intracellular transport. The advances in 
structural biology, molecular genetics, and fluorescence microscopy techniques over the 
last eight decades have enabled scientists to investigate actin extensively. Although a 
great deal of understanding has been acquired regarding the structure, function, and 
regulation of actin, further characterisation of actin microenvironments is required, 
particularly for the elucidation of actin isoforms, their localisation, and differential 
functions. The use of fluorescent probes in conjunction with advanced microscopy 
techniques has been instrumental in expanding the knowledge of actin within cellular 
landscapes. Spectral Phasor analysis is a technique that is capable of the hyperspectral 
characterisation of the spectral properties of individual fluorescent probes. Shifts in the 
spectral properties of probes can be linked to changes in the probes local 
microenvironment. Therefore, the further development of Spectral Phasor analysis for 
spectral characterisation is expected to lead to greater understanding of actin in cellular 
processes.  
This study investigates the use of Spectral Phasor analysis as a hyperspectral tool 
and its applicability to characterise the microenvironments of actin probes in actin 
filaments. This approach was applied to fluorescent actin probes, ActinGreen and ACTA1-
488, in a fixed cell model where the spectral properties of the probes were characterised 
and compared in their discrete binding domains on actin in various cellular regions and 
when influenced by the actin disruptor, Latrunculin A. The application of Spectral Phasor 
analysis for the characterisation of actin probe microenvironments revealed that 
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ActinGreen and ACTA1-488 exhibit characteristic spectral properties when bound in their 
respective domains in filament and nuclei regions. Further, distinct spectral properties 
were revealed for ActinGreen and ACTA1-488 when compared across the plasma 
membrane, cytoplasm, and nuclear membrane regions of fixed cells. Finally, shifts in 
spectral properties were observed in ActinGreen and ACTA1-488 microenvironments 
post treatment with Latrunculin A in both region of interest sets described above. 
The work conducted here demonstrates that Spectral Phasor analysis can be 
applied to characterise distinct spectral properties of fluorescent actin probe 
microenvironments in a fixed cell model based on differences in their binding domains, 
cellular environment, and in response to an actin disrupting compound. With ongoing 
development and optimisation, Spectral Phasor analysis can be applied to further 
hyperspectral characterisation of actin isoform microenvironments in fixed cell models, 





Chapter 1   
Literature Review 
 
The discovery of actin occurred in 1942 when a biochemist, Bruno Straub, was 
investigating factors that encouraged specific behaviours in discrete types of myosin.1 As 
a result of this investigation, techniques were developed that allowed for the extraction 
and isolation of actin.1 Through the continued study of actin over the next decade, Straub 
ascertained the mechanism behind the polymerisation of actin filaments, later postulating 
their involvement in muscle contraction.2-3 Since the discovery of actin almost 80 years 
ago, a great deal of understanding has been gained regarding its structure, function, and 
regulation.4-6 The developments in understanding actin and actin interactions reflects 
advances in structural biology, molecular genetics, and fluorescence microscopy 
techniques. Although these advances have helped to yield an immense amount of 
knowledge, further characterisation of actin is required, particularly when considering 
actin isoforms and their differential functions. This presents a need to develop applicable 
techniques for the further elucidation of actin microenvironments. Spectral Phasor 
analysis represents an advanced technique that utilises fluorescence to characterise 
spectral shifts associated with microenvironment changes throughout a cell. This study 
will test the ability of Spectral Phasor analysis to identify spectral shifts associated with 




1.1 Actin Structure and Function 
A fundamental principle of cell biology lies in the intrinsic relationship between 
structure and function. Actin is a highly conserved protein, abundant in eukaryotic cells 
and contributes to many crucial intracellular processes. These can include intracellular 
trafficking, structural organisation, muscle contraction, motility, cell division, and signal 
transduction.6-9 Actin exists in monomeric (G-actin) and filamentous (F-actin) forms and 
six tissue-specific isoforms.10 The ability for reversible polymerisation between G-actin 
and F-actin forms constitutes the basis for its dynamic functionality within cells and forms 
one of the three cytoskeletal networks. To further understand the nuances of actin activity 
in different cellular functions, we must consider its molecular characteristics. 
1.1.1 Globular and Filamentous Actin 
 
The structure of monomeric actin (G-actin) eluded scientists for years due to its 
polymerisation activity in the presence of salts, a condition required to grow crystals for 
X-ray characterisation.11 The actin:DNase I complex was reported to inhibit 
polymerisation and Kabsch et al. used this finding to aid in the determination of the three-
dimensional structure of monomeric actin.12-14 The actin monomer is composed of a single 
polypeptide chain consisting of 375 residues.15 The single polypeptide chain folds into 
two, similarly-sized domains separated by two clefts containing nucleotide-binding and 
target-binding sites.11,14,16  Although both domains are similar in size, they are named the 
small (DI) and large (DII) domains, with each domain containing two subdomains (SD). 
Subdomains 1 and 2 belong to DI and subdomains 3 and 4 belong to DII (Figure 1.1).  The 
peptide chain passes twice between DI and DII, resulting in the amino (N) and carboxyl 
(C) termini residing in DI.14 This link also forms a region that acts as a flexible hinge 
allowing for rotational movement of the two domains relative to each other.11, 16 Above 
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the hinge region, the nucleotide-binding site is located in a deep cleft in between SD2 and 
SD4. The nucleotide Adenosine triphosphate (ATP) or Adenosine diphosphate (ADP) is 
bound in this cleft complexed with Mg2+.  The binding of ATP or ADP to G-actin affects the 
conformation of the molecule. Without a bound nucleotide, G-actin denatures rapidly.17 
Below the hinge region, there is a target-binding site known as the hydrophobic cleft 
located in between SD1 and SD3. This highly adaptable site is primarily associated with 
actin-binding protein (ABPs) interactions.17 At the front end of this site, there is a related 
section, the hydrophobic pocket, known to mediate protein-protein interactions.17,18 
Another notable molecular feature of G-actin is the DNase-binding loop (D-loop) situated 
in subdomain 2.14  
Shortly after Kabsch et al. reported the atomic model of G-actin in complex with 
DNase I, Holmes et al. reported on the atomic model of the actin filament (Figure 1.1).14, 
19 The actin filament consists of two strands which wind around the back of one another 
to form a two-stranded helix. The segments of the two-stranded filaments appear to 
repeat every 36 nm while the diameter varies between 7 and 9 nm.19 A model reported 
by Oda et al. shows that a fundamental difference between G-actin and F-actin is the 
relative rotation of the two domains.20 In G-actin, the two domains are twisted, whereas, 
in F-actin, there is a 20° rotation between DI and DII resulting in flattening of the filament. 
This flattening generates extensive inter, and intrastrand contacts between the subunits. 
Individual subunits in the filament make contact with one subunit directly above and 
below in the strand, as well as two subunits in the other strand.20 The native helical 
disposition of the subunits in combination with flattening of the filament is a major 
stabilising component of the structure. In this model, the D-loop contacts the hydrophobic 




The subunits are all oriented in the same direction, which lends to the polarity of 
the filaments. Due to the polarity of the filaments, the charge at each end differs. These 
are designated the barbed (+) and pointed (-) ends. The (+) end favours the addition of 
subunits while the (–) end favours the dissociation of subunits. With the addition subunits 
to the (+) end, the nucleotide-binding cleft of the terminal actin contacts the neighbouring 










Figure 1.1 Structures of monomeric G-actin and filamentous F-actin. 
A) The structure of monomeric G-actin, which is divided by a nucleotide binding cleft into two similarly sized domains, 
further divided into four subdomains, numbered SD 1-4. ATP (yellow) binds at the bottom of the nucleotide binding 
cleft and contacts both domains. The N- and C- termini reside in subdomain 1. PDB structure ID: 2BTF 21 B) The 




1.1.2 Actin Isoforms 
 
As actin has a highly conserved family of genes,  the actin cytoskeleton is present 
in many different cell types interacting with various actin-binding and regulatory 
proteins. All eukaryotes express at least one isoform of actin, however it is not uncommon 
for species to express more isoforms. In vertebrate species the number of actin-
expressing genes varies, however it appears that most mammals express six actin 
isoforms and their tissue-specific expression denotes their differential roles.10 There are 
four muscle isoforms, alpha-skeletal muscle actin, alpha-cardiac muscle actin, alpha-
smooth muscle actin, and gamma-smooth muscle actin. As well as two non-muscle actins 
which are beta- and gamma-cytoplasmic actin. The classification of alpha, beta, and 
gamma are derived from a difference in isoelectric point.24 The difference in isoelectric 
point arises from the type and number of acidic residues at the N terminus.10 Despite this, 
the primary structure of actin is conserved which suggests that the isoforms present 
similar surfaces and fold.25 This is further supported by experiments which show 
chaperonin CCT is required to fold beta-cytoplasmic actin, alpha-skeletal actin, and alpha-
cardiac actin into their native state.26 Moreover, the slight divergence in sequence and 3D 
structure between isoforms has been indicated in subtle differences in the polymerisation 
process and affinities for actin-binding proteins.25, 27 Evidence for this has been produced 
in various comparative studies. For example, it was revealed in a study by Shuster et al.28 
that the ABP BetaCap73 preferentially binds beta-cytoplasmic actin over alpha-skeletal 
muscle actin. Further, Prochniewicz et al. observed comparative affinities for binding of 
cofilin 1 in F-actin composed on alpha-skeletal muscle actin or on of the two cytoplasmic 
actin variants.29 Additionally, Yamashiro et al.  showed that although tropomyosin-bound 
tropomodulins 1 and 3 exhibited no difference in capping capability of alpha-skeletal 
muscle actin in comparison to beta-/gamma-cytoplasmic actin, tropomodulin 3 did 
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preferentially sequester beta-/gamma-cytoplasmic actin when tropomyosin was 
absent.30 Altogether these comparative studies highlight that further understanding of the 
differential interactions between actin isoforms and actin-binding proteins poses a 
significant biological challenge in the field of actin research.25 
1.1.3 Actin Dynamics 
The actin cytoskeleton is a highly regulated network consisting of filaments that 
provide structure while simutaneously facilitating dynamic cellular processes. Reversible 
polymerisation between G-actin and F-actin forms the basis for the dynamic and varied 
functionality of actin within cells. In physiological conditions, the ionic strength of the 
solution influences the polymerisation activity of F-actin. Increasing the ionic strength 
with the addition of cations (Mg2+, K+, and Na+) induces the polymerisation of G-actin into 
F-actin.31 Conversely, decreasing the ionic strength will cause F-actin to dissociate back 
into G-actin. The process of actin polymerisation proceeds in three sequential phases: 
nucleation, elongation, and the steady-state phase (Figure 1.2). 
In the nucleation phase ATP-G-actin is sequestered by nucleation factors such as 
formins and Arp 2/3 complex from a pool of profilin-bound actin monomers.32 Formins 
catalyse the formation of unbranched filaments and assemble various actin structures 
such as stress fibers, cytokinetic actin rings, and actin cables in vivo.33, 34 In contrast, the 
Arp 2/3 complex when combined with nucleation promoting factors such as WASp, SCAR, 
or WAVE, can induce the polymerisation of a new filament branching from and already 
existing filament.34 Once nucleated, the elongation phase proceeds and filaments begin to 
grow at both ends. Formins have also been reported to function as ‘actin elongation 
factors’ and are reported to ‘crown’ the barbed end and move with the growing filament.33 
Elongation continues until either the concentration of the G-actin pool decreases and 
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steady-state is reached when equilibrium is achieved between monomers and filament 
ends, or the elongation process is terminated by capping proteins.33 When filaments 
achieve steady-state they can undergo treadmilling (Figure 1.3).36 This treadmilling 
phenomenon is powered by the hydrolysis of ATP. When ATP-G-actin binds to the barbed 
(+) end of a filament, ATP is hydrolysed to ADP + Pi. The subsequent release of Pi from 
subunits in the filament results in asymmetry with ATP-G-actin at the barbed (+) end, 
followed by a region of ADP-Pi-actin, followed by ADP-actin at the pointed (-) end after 
the release of Pi. The hydrolysis of ATP and the release of Pi results in a comformational 
change that influences the association and diassociation rates at the ends of the filament. 
ATP-G-actin is preferentially added at the barbed (+) end while ADP-G-actin subunits 
dissociate from the pointed (-) end.  
  
Figure 1.2 The three phases of G-actin polymerisation. 
The process of actin polymerisation proceeds in three sequential phases. In the nucleation phase G-actin is sequestered 
by actin nucleating proteins, such as Arp 2/3 or formins, to form a “seed” or “nucleus”. During the elongation phase, 
the nuclei are rapidly elongated by the addition of subunits occurring at both ends of the growing filament.35 Steady 















The dynamics of actin filament turnover are further regulated by proteins such as 
profilin, cofilin, and thymosin-β4. Profilin is responsible for mediating the exchange of 
ADP to ATP in dissociated ADP-G-actin. Firstly, profilin binds to the side opposite the 
nucleotide-binding cleft of dissociated ADP-G-actin and causes the cleft to open allowing 
ADP to be exchanged for ATP resulting in a profilin-ATP-actin complex.32, 37 Cofilin 
mediates the dissociation of actin subunits from the pointed (-) end by binding and 
bridging two subunits and inducing a conformational change to the filament.36 This 
change in conformation destablises the filament and results in subunits breaking away. 
The dissociated subunits are then ‘recharged’ by profilin. Thymosin-β4 maintains the pool 
of available ATP-G-actin by inhibiting the addition of subunits to either end of the 
filament.38 A dynamic equilibrium exists between free actin and thymosin-β4. If free actin 
is sequestered for polymerisation, actin bound thymosin-β4 will dissociate, making more 
actin available. Therefore, thymosin-β4 elicits a buffering effect on unpolymerised actin, 
making it available when required.  
The biochemistry of actin is inherently complex due to the multistep 
polymerisation process which is linked to nucleotide status and the relationships with a 
Figure 1.3 Actin treadmilling. 
Upon reaching steady state actin filaments can undergo treadmilling. Powered by the hydrolysis of ATP, treadmilling 
begins with ATP-G-actin binding to the (+) end of the filament. The ATP is then hydrolysed to ADP + P i, following the 
release of Pi from the subunits an asymmetry occurs within the filament with ADP-G-actin at the (-) end and ATP-G-
actin at the (+) end. The resulting conformational change in the filament influences the association and 
disassociation rates at the end of the filaments. ATP-G-actin is preferentially added to the (+) end, while ADP-G-actin 




multitude of actin-binding proteins, few of which were described above. A great deal is 
understood about the dynamics of actin assembly and the related protein interactions. 
However, further understanding of how changes in local actin microenvironments affects 
these dynamic processes is required. As actin plays distinct roles in different regions of 
the cell, the local microenvironment surrounding the actin molecules likely influences 
interactions and dynamics. This could be useful when considering different isoforms of 
actin and their differential functions and binding affinities. 
1.1.4 Roles of Actin in the Cell 
As one of the most abundant proteins in eukaryotic cells, actin is essential in many cellular 
processes such as intracellular trafficking, motility, cell division, muscle contraction and 
differentiation.6-9 In order to carry out such a diverse range of functions actin interacts 
with many proteins in different subcellular compartments.  
Beneath the plasma membrane there is a thin crosslinked network of actin 
referred to as the cortex and it plays a crucial role in cell shape control. The cortex acts 
much like a cell wall in bacterial or plant cells, with involvement in determining the 
stiffness of the cell surface and resisting external mechanical stresses.39 However, unlike 
a cell wall the cortex can undergo dynamic remodelling in animal cells allowing for rapid 
adaption to extracellular stresses.39 Further, in motile cells responding to extracellular 
stimuli actin filaments are polymerised at the plasma membrane to produce protrusions 
called filopodium and lamellipodium, structures crucial for motility and environmental 
sensing. As cells traverse through the environment, these protruding regions adhere to an 
anchorage point through another actin mediated structure, focal adhesions.39 In addition 
to migration, actin at the plasma membrane has crucial roles in myogenesis and the fusion 
of myoblasts and myotubes. Extensive remodelling of the actin cytoskeleton is required 
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for the fusion events.40, 41 Schnorrer and Dickson showed that myotubes elongate at their 
ends while simultaneously fusing with myoblasts at the center of a fiber.42 Further, 
Massawra et al. investigated fusion in Drosophila and found that the WASp-Arp2/3 
complex, actin nucleating factors, are essential for fusion to occur between maturing 
myotubes and “fusion capable myoblasts”.43 
Actin is not only essential for cell shape and motion; it is also important for the 
organisation and dynamics of organelles and vesicles in the cytoplasm.44 The formation 
of actin filaments at intracellular membranes drives intracellular processes by providing 
the mechanical forces necessary for autophagy, exocytosis and endosome sorting and 
recycling.45 Further, cell spanning actin filaments facilitate molecular transport of 
vesicular cargo through association with myosin motor proteins.46-48 Similarly to the 
maintenance of cell morphology at the plasma membrane, actin dynamics at the nucleus 
are reported to regulate nuclear morphology via several actin structures, including actin 
caps and actin cables.49, 50 Maninova reports that the central portion of the actin cap fibers 
are physically attached to the nucleus through the LINC complex, a linker of the 
nucleoskeleton and cytoskeleton.51 Moreover, actin cap associated focal adhesions can 
simultaneously serve as a conduction path of mechanical signal and discharge stress 
transferring onto the nucleus.50 Actin cables are coupled to the nuclear envelope through 
LINC complex proteins which accumulate along these cables, inducing the formation of 
linear assemblies called transmembrane actin-associated nuclear (TAN) lines. These TAN 
lines span the nuclear envelope.52, 53  
As actin is involved in many cellular processes and interactions, the composition 
of actin microenvironments is unique due to spatial and temporal characteristics such as 
cellular region and stage of differentiation. These factors require close consideration 
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when attempting to characterise actin microenvironments in subcellular regions. For 
instance, at the plasma membrane actin participates in a variety of activities with many 
binding partners. In differentiating myotubes, filopodia protrudes at each end of the cell 
and interacts with integrins to maintain focal adhesions, while the actin cortex is 
dynamically responding to extracellular stresses. This is an example of a region, the 
plasma membrane, and three unique microenvironments which are the filopodia, focal 
adhesions, and actin cortex where actin is involved in distinctive processes. Further 
investigation of actin in the context of its microenvironments with techniques such as 
Spectral Phasor analysis has the potential to further current knowledge. 
1.1.5 Latrunculin A – An Actin Disrupting Compound 
Latrunculin A (Lat-A) is a type of marine toxin that is purified from the red sea 
sponge Latrunculia magnifica. It was initially tested on non-muscle cells and identified as 
an inhibitor of actin polymerisation due to its impact on actin filament distribution and 
morphological effects.54 Further studies on the effects of the toxin focused on its effects 
on the steady state of F-actin in vitro and data has been consistent with Lat-A sequestering 
G-actin in a 1:1 stoichiometric ratio.55, 56 Lat-A binds to actin in the nucleotide-binding 
cleft, adjacent to the ATP binding site, and through extensive interactions within the cleft, 
is it suggested that actin is locked into the monomeric conformation (Figure 1.4).55-58 The 
interactions of Lat-A with the sides of the cleft is thought to restrict the scissor-like motion 
required for flattening the subunits and subsequently prevent their incorporation into the 
filaments.20, 59, 60 Yarmola et al. report that Lat-A inhibits the adenine nucleotide exchange 
on actin. A comparison is drawn to DNase I, which bridges the cleft between subdomains 
II and IV, reducing the rate of adenine nucleotide exchange.55 Therefore, it is suggested 
that Lat-A binding may limit the flexibility of the cleft, trapping the nucleotide, and 
thereby reducing nucleotide exchange.55, 61 These described mechanisms could explain 
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Lat-A affinity for G-actin and the subsequent sequestration and inhibition of nucleotide 










Although Lat-A preferentially binds to G-actin, it still affects actin filaments 
through severing and depolymerisation. Fujiwara et al.  observed that Lat-A promotes the 
disassociation of subunits from the ends of filaments assembled from ATP-actin 
monomers.60 Findings by Morton et al. indicate that the binding of Lat-A may act to 
prevent the dissociation of the nucleotide by bridging of subdomains II and IV.57 
Furthermore, Morton et al. suggests conformational changes induced by Lat-A binding are 
limited to specific regions, rather than the entire structure. Specifically, the two loop 
structures at the tops of subdomains II and IV. These loops propagate the subunit-subunit 
interface but also accommodate binding by Lat-A and this is thought to influence crucial 
subunit contacts.57 Fujiwara et al. suggest that Lat-A bound to a single subunit in a 
filament will destabilise it locally and lead to severing.60 They acknowledge that these 
Figure 1.4 The actin disrupting compound Latrunculin A. 
A) The chemical structure of Latrunculin A.62 B) An actin monomer with Latrunculin A (magenta) and ATP 





events require high concentrations of Lat-A due to its low affinity for polymerised actin. 
Conversely, Lat-A at low concentrations is reported to induce rapid disassembly of 
filaments within tens of seconds in animal and yeast cells.54, 58  It is thought that low 
affinity for polymerised actin is due to the interior subunits of the filament being flattened, 
as well as the four surrounding subunits limiting the opening of the cleft to bind Lat-A. 
Fujiwara et al. suggest two new mechanisms by which Lat-A disassembles filaments in 
cells.60 First, is the severing mechanism described previously, Second, they propose a 
mechanism of rapid “aging” of the filament due to fast phosphate dissociation from 
terminal ADP-Pi-actin subunits, increasing rates of subunit dissociation from both ends of 
filaments.60 It is also noteworthy that the severing of filaments can increase the number 
of filament ends for depolymerisation.60 Increased depolymerisation from both ends of 
filaments accelerates the disassembly of any uncapped filaments. Although, many actin 
filaments in cellular environments appear to be capped by capping proteins, preventing 
disassembly.64 Formin FH2 domains are also reported to prevent rapid depolymerisation 
by Lat-A. 
Lat-A is extensively used in live cell experiments where disruption of the actin 
cytoskeleton is desired. By observing the disruption of actin structures in real-time, 
characterisation of Lat-A:actin complex interactions have been further characterised. This 
was highlighted above by the Fujiwara et al. study, where they propose two additional 
mechanisms by which Lat-A disrupts actin.60 Their study used total internal reflection 
fluorescence (TIRF) microscopy in conjunction with fluorescent actin probes to 
investigate the effects of Lat-A on actin binding, filament nucleotide state, and 
depolymerisation.60 This represents one possible approach for the visualisation of actin 
in a live cell environment.  
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1.2 Approaches to Actin Visualisation  
The dynamic nature of actin and its relationships with various ABPs lends to its 
varied functionality within a multitude of cellular processes. Investigating actin and actin-
related functions relies heavily on the capability to visualise actin structures. Therefore, 
the study of the actin cytoskeleton has relied heavily on fluorescent probes based on 
toxins (phalloidin), peptides (LifeAct), or ABPs (utrophin). Thus far, the development of 
visualisation techniques has been an invaluable tool for unravelling the activity of actin in 
cellular environments. Several methods for the characterisation of actin and actin-related 
structures have been developed. 
1.2.1 Actin Visualisation in Live Cells 
The dynamic nature of actin presents challenges when trying to visualise specific 
actin structures and their related functions under real-time conditions in living cells. 
Although challenging, there are various options available for the characterisation of actin 
within live cells. These include genetically encoded GFP-actin, genetically encoded actin-
binding domains (ABDs) which are fused to GFP derivatives, actin-directed nanobodies, 
and chemically synthesised probes.65 When deciding on a particular actin-detection 
probe, the cellular context of the study should be closely evaluated to reflect the actin 
structure of interest. All actin probes have limitations and can alter endogenous actin 
dynamics to varying degrees. For example, success with probes such as LifeAct, Utrophin, 
and F-tractin appears to depend on the model organism or cell line used.65 Further, some 
actin probes may display differential cytoskeletal architecture as some markers are 
excluded from specific actin filament structures. In a study by Belin et al. the distribution 
of GFP-actin and ABP derivatives (LifeAct, Utrophin, and F-tractin) was observed in living 
cells.66 They found the actin-binding probes insufficiently stained filopodia-rich regions, 
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whereas GFP-actin incorporated well into filopodia. Additionally, it was found that GFP-
actin was excluded from stress fibers and lamellar filaments, reflecting incompatibility 
with other endogenous actin-binding proteins. Another limitation of genetically encoded 
actin probes is that they cannot distinguish between specific actin isoforms. However, 
antibody-based approaches have been developed recently to combat this. 
1.2.2 Actin Visualisation in Fixed Cells  
Fixed cell analysis is an alternative to live cell analysis where visualising actin in 
real-time can be challenging. Fixed cell analysis allows for the observation of cellular 
components preserved at a specific points in time. Actin structures in fixed cells can be 
visualised by a number of different methods including antibodies, fluorescently-labelled 
phalloidin, and endogenously expressed probes. 
 Fluorescence is a valuble tool for studies that require actin visualisation. When 
selecting specific actin probes, such as phalloidin and antibodies, fixation protocols are 
generally required for their successful application due to their low permeability of cell 
membranes.65 The two types of fixation which will be focused on are crosslinking and 
dehydrating/precipitating. Fixatives used to achieve crosslinking are aldehydes. 
Formaldehyde is a widely used fixative for a wide range of cells and tissues that results in 
low levels of cell shrinkage and preservation of cellular structure.67, 68 Formaldehyde 
induced crosslinking in cells occurs through reactions primarily with basic amino acids 
and results in the formation of methylene bridges.69 Although formaldehyde is widely 
used, this type of fixation is not suitable for all applications and does have drawbacks. For 
instance, it has been indicated that formaldehyde can induce blebbing effects at the 
plasma membrane and vacuole formation close to or on nuclear and mitochondrial 
membranes.70 Futher, fixatives such as formaldehyde are not suitable for antibody probes 
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due to their binding sites being obscured by the effects of crosslinking. This is where 
precipitating fixatives are a more approriate choice. Methanol is an organic solvent 
commonly used for cell preservation through dehydration and precipitation of lipids. 
Often used in immunostaining applications, methanol can provide high levels of 
immunostaining with low background and non-specfic staining.71 However, fixation by 
methanol is not suitable for staining with phalloidin, as it can destroy the native 
conformation of F-actin thereby disrupting the binding of phalloidin.65 In a study by 
Meade et al. the effects of chemical fixation on three human cell lines were analysed 
through micro-Raman spectroscopy.69 Three commonly used fixatives for preserving 
proteins and nucleic acids were selected: formalin, Carnoy’s fixative and methanol-acetic 
acid. The spectral content of the cell lines in their live and fixed forms were compared and 
revealed that all fixatives had some effect on the vibrational modes of lipid, protein, 
carbohydrate, and nucleic acid moieties.69 Although, there were differences in the 
molecular species affected and the levels of change. Meade et al.  concluded that formalin 
fixation presents a cellular spectrum that is universally more similar to that of a live cell 
and out of the fixatives studied best preserves cellular integrity.69 While there is no ‘one 
size fits all’ fixation method for every application, Hobro and Smith offer suggestions for 
their most appropriate uses.72 First, if spectral similarity to live cells is desired they 
suggest the use of paraformaldehyde at the cost of potential blebbing and vacuole 
formation. Second, where preservation of biomolecular distribution and preservation of 
cellular structure is important, they suggest a mix of paraformaldehyde and 
glutaraldehyde at the cost of changes to some spectral profiles.72 As fixation protocols are 





1.2.3 Actin Specific Fluorophores 
The visualisation of actin requires a careful selection of probes to ensure that the actin 
structure of interest is being observed. Currently there are several types of actin probes 
on the market with many types of fluorescent conjugates. Some common probes include 
fluorescently conjugated peptides and actin binding proteins (LifeAct and Utrophin), 
toxin-based probes (phalloidin and jasplakinolide derivatives), antibody probes, and 
endogenously expressed probes such as GFP actin.65 
In this study the actin probes ActinGreen and ACTA1-488 are used and they have 
the same fluorophore conjugate, Alexa 488. A rhodamine-derived fluorescent dye, Alexa 
488 was synthesised through the sulfonation of rhodamine, a derivative of xanthene, by 
substituting one or more hydrogen atoms in the molecule structure with sulfonic acid or 
one of its salts.73 Rhodamine is a zwitterionic molecule that is water-insoluble, the 
introduction of sulfonic acid groups adds negative charge on the molecules making them 
more hydrophilic. This is advantageous because increased water-solubility allows for 
conjugation to be carried out in the absence of organic solvents.73 The net negative charge 
of the dye also decreases interactions between molecules that can interfere with 
fluorescence yields of rhodamine conjugates. Alexa 488 is reported to exhibit greater 
photostability and fluorescence output than its commonly used counterpart, fluorescein 
(Figure 1.5).73 The excitation and emission maxima of Alexa 488 are 495/518 nm, 
respectively. Due to its robust photostability and fluorescence output, Alexa 488 is a 
popular candidate for conjugation to common reporter molecules. In this project two 
types of actin probes conjugated with Alexa 488 are utilised. The first is the Alexa Fluor 
488 phalloidin probe, ActinGreen™.74 The second is the primary monoclonal antibody, 
HHF35 conjugated with Alexa 488. The conjugation of Alexa 488 to these molecules 





This project uses the phalloidin-based probe ActinGreen, which is an Alexa Fluor 
488 conjugate with a molecular weight of 1320 Da.81 Fluorescently labelled phalloidin is 
currently the gold standard for labelling endogenous filamentous actin in fixed cells. The 
use of phalloidin as a probe is largely restricted to fixed cells due to its low permeability 
for cellular membranes and stabilising effects on actin filaments in vivo and in vitro.82-84 
Actin structures visualised by fluorescent phalloidin are usually altered to a certain 
degree by the necessary permeabilisation and fixation protocols. Therefore, it is possible 
for artifacts to occur depending on the protocol used. With these points in mind, results 
should be interpreted carefully.  
The second probe, HHF35, is a primary monoclonal antibody conjugated to Alexa 
488. This antibody recognises the alpha muscle actin isoform in both G- and F-actin 
conformations and is referred to in this project as ACTA1-488.85, 86 The HHF35 antibody 
is an IgG1 isotype with a molecular weight of 150 kDa (150,000 Da). The six isoforms of 
actin differ based on differences in isoelectric point and amino acid sequence at the N-
terminus.10 Tsukada et al. used these differences to synthesise and characterise the 
HHF35 antibody.86 There is little literature available on the specific binding site of this 
antibody. As HHF35 has specificity for alpha muscle actin and isoforms differ at the N-
terminus, it may be inferred that HHF35 recognises the N-terminus as the unique epitope 
for binding. 
1.2.4 Fluorescence Microscopy 
Fluorescence microscopy is an essential part of the toolkit in biological and 
biomedical research and has been instrumental in expanding the understanding of 
cellular components and molecules. Through the use of various fluorescent probes or 
endogenous autofluorescence, spatial and functional information can be collected. The 
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visualisation of sub-microscopic targets within cells is made possible through the 
prinicples of fluorescence. When utilising fluorescence, firstly, the target molecules are 
irradiated by a laser at their excitation wavelength, this is followed by their emission 
being collected at a different wavelength.87, 88 The principles of fluorescence microscopy 
can be applied to ActinGreen and ACTA1-488 to study actin in fixed cells. There are  
numerous pieces of equipment and techniques currently available to collect and analyse 
fluorescence data in a sample. However, not all fluorescence microscopy techniques are 
made equal and there are limitations. For example, in widefield fluoresence microscopy, 
the whole sample is illuminated and this can result in high background and bleedthrough 
of dyes with overlapping spectral properties. Additionally, wavelength excitation bands 
depend on the filter sets available to the user and this can be a limiting factor in dye 
selection.89  
1.2.5 Confocal Microscopy 
Confocal microscopy can expand on the uses and limitations of widefield 
fluorescence microscopy. Where widefield microscopes illuminate a whole sample with 
light, confocal microscopes use focused laser beams. This allows the selection of specific 
lasers for wavelengths at or near the appropriate excitation range for the fluorescent 
probe being used in a sample. The laser is used to scan across a specific region of the 
sample to produce optical slice images.90 First, the focused laser beam used to excite the 
fluorophore is passed through a dichromatic mirror. When the laser beam hits the 
fluorophore it will begin to fluoresce and the subsequent fluorescent emission is captured 
and passed back through dichromatic filter and into the Photon Multiplier Tube (PMT).91 
Prior to entering the PMT, the fluorescent emissions first pass through a pinhole in front 
of the PMT detector. This minimises the background fluorescence from other focal planes 
and increases the resolution of the cell images as a result. 92  
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The laser scanning of a sample can occur in three dimensions (3D) ‘x’, ‘y’, and ‘z’. 
This allows for multiple opitcal slice acquisitions that can be further processed to produce 
3D images.90, 92 Additionally, temporal information can be collected and analysed by the 
incorporation of the fouth dimention by use of the time scan function. The advancements 
in fluorescence microscopy technology has made confocal microscopy an essential tool in 
studies involving subcellular localisation and protein-protein interactions. Furthermore, 
it is compatible with techniques such as fluorescence lifetime imaging (FLIM), 
fluorescence recovery after photobleaching (FRAP), and förster resonance energy 
transfer (FRET).    
1.2.6 Förster Resonance Energy Transfer 
Förster Resonance Energy Transfer (FRET) is an effective and high-resolution 
method used to evaluate molecular interactions in live and fixed samples. As FRET is 
capable of nanometer resolution (1-10 nm), it is widely used to investigate the molecular 
mechanisms governing cellular processes such as gene expression, second messenger 
cascades, and vesicular transport.93, 94 FRET is a distance-dependent photophysical 
process that occurs between a donor molecule in the excited state and an acceptor 
molecule in the ground state. Typically, the donor emits at shorter wavelengths which 
overlap with the absorption spectrum of the acceptor. The energy transfer is the result of 
nonradiative long-range dipole-dipole interations between the donor and acceptor and 
occurs without the appearance of a photon.95, 96 This is to say, the energy transfer process 
does not involve the emission and reabsorption of photons. The resonance energy 
transfer concept is based on the fluorophore as the oscillating dipole which can exchange 
energey with another dipole of similar resonance frequency.95 The rate of energy transfer 
between donor and acceptor molecules is dependent on a number of variables. This 
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includes the extent of spectral overlap in emission spectrum of the molecules, the donors 
quantum yield, the orientation of the donor and acceptor transition dipoles, and the 
distance between the donor and acceptor molecules.95  
In the context of actin, FRET has been used extensively to determine radial 
coordinates of amino acids and to study the assembly of actin filaments.97-99 Moens and 
dos Remedios were the first to show that FRET can be used to localise a probe within the 
three-diemnsional space in actin filaments. They achieved this by using the nucleotide 
binding site as a reference point in a monomer with a bound fluorescent ADP analogue 
(donor) and compared it to a probe bound to the Cys-374 residue (acceptor) in F-actin.99 
The results were combined with radial coordinate distances and 3D positioning of the 
probe was revealed. They found that the position of the probe in F-actin was consistent 
with the model proposed by Lorenz et al.100 Although the application of FRET has been 
successfully applied to study probe localisation within actin filaments it does have 
limitations. Several disadvantages of FRET include its the low signal-to-noise ratio and 
the requirement for spectral bleed through corrections.101 The Spectral Phasor approach 
is used in this study to minimise and overcome the limitations posed by FRET. 
1.2.7 Spectral Imaging  
 Spectral imaging is the combination of two well established methodologies, 
spectroscopy and imaging.  Established imaging techniques provide the intensity of each 
pixel in an image (x, y), while a spectrometer provides a single spectrum (λ). Spectral 
imaging blends the two by providing a spectrum at each pixel (x, y, λ) to produce a three-
dimensional image (Figure 1.6).102 The resulting 3D data set can be thought of as a collection of 
many images where each one is measured at a different wavelength or as a collection of many 
spectral values at each pixel in an image.102 Because spectral images contain significantly 
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more data than a single colour image, acquisition time is impacted which is challenging 
for live cell applications. Compromises must be made on the spectral resolution of an 
image if temporal information is required.102 Spectral imaging coupled with linear 
unmixing allows for the use of multiple fluorophores with overlapping emission 
spectra.103 This is simultaneously a strength and a challenge in spectral imaging.  For 
instance, to unmix overlapping emission spectra of multiple probes, prior knowledge of 
the probes’ respective reference spectra is required as well as complex algorithms for the 
analysis of spectral data.102 While spectral imaging is a powerful tool for extracting large 
amounts of data from single pixels in images, a simplified approach to analysis is required 







Figure 1.7 Visual representation of spectral scan parameters. 
The capture of spectral datasets involves the acquisition of fluorescence intensity data for each pixel in the x/y focal 
plane. This is repeated in successive steps across a user-defined spectral range, represented here by λ. The number 
and size of the steps and the range of acquisition can be adapted for different spectral resolution requirements. This 




1.3 Spectral Phasor Analysis 
Spectral Phasor analysis is a method which allows for the fast and reliable 
unmixing of overlapping spectral data and the quantification of spectral emission profiles 
without prior knowledge of a probes influence on fluorescence spectra. 104 This provides 
a simple visual approach for analysing large spectral images while maintaining 
compatibility with commercial microscopes.105    
 Fluorescence data is acquired via a confocal microscope using the xyλ scan mode. 
The xy focal plane captures fluorescence intensity data at user-defined intervals across a 
spectral range which is defined by the λ plane. As a result, each set of data produced by 
the xyλ scan mode consists of an emission spectrum for each pixel in the corresponding 
image. The emission spectra for each pixel is Fourier transformed using equations 
(Equation 1.1) to generate two numbers, the amplitude and phase.105, 106 The amplitude 
and phase correspond to the label’s ‘g’ and ‘s’, respectively. Further, these values are used 
as X- and Y- coordinates to construct a phasor plot. In Equation 1.1, ‘L’ is the total 
wavelength range, ‘I(λ)’ is the intensity at a given wavelength and given pixel, and ‘n’ is 
the harmonic order of transformation.105 The phasor plot area covering an angle of ¾ π 
radians for the first harmonic compared to 4 π radians for the second harmonic. The first 
harmonic becomes deformed at shorter wavelengths.105 In contrast, the second harmonic 
is more linear, allows resolving of spectral species that have close emission wavelengths, 
and is less impacted by distortions at shorter wavelengths. This means that the second 
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The resulting phasor plots are a simple graphical representation of the emission 
profiles of pixels derived from the emission spectra of the original image. Emission 
profiles can appear in single or multiple distinguishable clusters, where clusters show 
relationships between collections of pixels with similar emission profiles. The emission 
profiles of pixels are clustered based on similarities in their amplitude and phase; where 
similar emissions are clustered together, and those that are increasingly dissimilar are 
further apart.104, 105 Each pixel on the phasor plot represents a unique spectral profile 
consisting of an emission maximum (λmax) and spectral width. The position of λmax is 
plotted anti-clockwise around the phasor, increasing in wavelength. The spectral width is 
inversely proportional to the radial distance from the origin (Figure 1.8).104, 105, 107, 108 That 
is, the further from the origin the narrower the spectral width, the closer to the origin the 
broader the spectral width, with background fluorescence located at the origin.106 
Spectral profiles can be observed on the phasor plot using cursor analysis. As cursors are 
moved across the phasor, pixels which correspond with the selected region are translated 
into pseudo-coloured hotspots on the original image. Cursor analysis allows for pixel scale 
mapping of fluorescent phenomena and spatial mapping of discrete emission profiles.105, 
106 Because multiple spectral profiles are displayed at one time, an average λmax and 
spectral width value are displayed. The shape and size of the cursor can be modified to 
target more specific spectral profiles within a spectral image to achieve greater accuracy 




1.3.1 Advantages of applying the Phasor Approach to Spectral Analysis 
Variations of fluorescence microscopy techniques are commonly used to study the 
colocalization of multiple components in cellular environments. Fluorescent probes are 
available in numerous variants with distinct spectral properties and serve as invaluable 
tools in many life-science applications. Despite this, imaging multiple cellular components 
simultaneously can be difficult.102 104 One primary reason for this is the potential for 
highly overlapping emission spectra of selected probes. This presents challenges when 
trying to achieve reliable dye separation because large amounts of fluorescence need to 
be discarded.103 The application of spectral imaging in combination with linear unmixing 
is advantageous in this regard as it can discriminate discrete emission spectra which may 
not be distinct in a fluorescent image. 
 The phasor approach, when applied to spectral analysis, is distinct from typical 
spectral analysis techniques. Traditionally, spectral analysis requires minimal 
background noise to obtain the most reliable unmixing of closely overlapping emission 
spectra through the application of complex algorithms.102 One drawback of linear 
unmixing is that it requires prior knowledge of fixed reference spectra. There is also a 
possibility that the reference spectra used will introduce artefacts.102 This occurs because 
the emission spectra of dyes are dependent on their local environment, and their spectra 
in cells may differ from those in solution.102, 104-106 Therefore, extensive calibration efforts 
are required to correct for this. The application of the phasor approach can mitigate the 
limitations of traditional spectral analysis. 
 The phasor approach provides a global analysis of an entire spectral image 
through the production of a phasor plot. This graphical representation is generated 




1.3.2 Applications of Spectral Phasor Analysis 
Previously the Spectral Phasor approach has been applied to characterise various 
cellular microenvironments both in vitro and in vivo. In dual studies by Andrews et al. the 
shifts in emission spectra of the RNA dye, ‘Pyronin Y’ (PY), were used to elucidate RNA 
associated microenvironments and discrete RNA species.107, 108 In the first study, Andrews 
et al. successfully determined at least three RNA populations which localised within 
distinct cellular regions.108 In Figure 1.9, the RNA populations are shown by cursor 
analysis. The regions in the nucleoli and cytoplasm highlighted by the yellow cursor 
shared similar spectral properties which inferred the presence of two distinct RNA 
species, mRNA and mRNP complexes. Two other species of RNA were isolated in the 
nucleus and cytoplasm by the blue and purple cursors, respectively.108 The second study 
by Andrew et al. utilised PY labelled RNA to distinguish discrete transcripts of RNA in live 
fibroblasts.107 The shifts in spectral properties of the PY labelled RNA aided in the 
identification of at least six different RNA species. Through cursor analysis, the 
differentiation of clusters at detectable phasor locations appeared spatially separated and 
independent in images.107 The ability to identify six discrete species of RNA directly in 
their biological environment demonstrates the sensitivity of the Spectral Phasor 
approach at a single-molecule level.107 Additionally, these studies show that one dye can 
have a range of spectral properties, dependent on cellular microenvironments and 




observed shifts in the emission spectra of AF components in tissue at increasing depths. 
The resulting phasor plots revealed regions of interest used to identify the discrete AF 
components, which were NADH, FAD, keratin, collagen, melanin, and elastin.109 
Interestingly, Spectral Phasor analysis was able to discriminate between cells based on 
their melanin concentration.104 Image segmentation was also possible based on spectral 
features, and various structures in the skin were also distinguishable (stratum corneum, 
epidermis, and dermis).  
 As previously described in section 1.2.3, the actin probes selected for this study 
are the phalloidin-based ActinGreen and antibody-based ACTA1-488. Despite both 
probes being conjugated to the fluorophore, Alexa-488, there are distinct differences in 
their physical size, binding domains, and actin targets (Appendix A1.1). Spectral Phasor 
analysis may detect hyperspectral shifts within their local microenvironments based on 
these properties.  
1.3.3 Limitations of Spectral Phasor Analysis 
Spectral Phasor analysis has many promising applications; however, it is not 
without limitations. These limitations mainly pertain to the process of acquiring the 
spectral image. Acquiring xyλ scans can be time-consuming when scanning across the 
whole spectrum is required.102 Extended exposure time to the laser can cause 
photobleaching in susceptible fluorophores. As a result, photobleached fluorophores will 
produce weak emission spectra that will translate poorly during analysis.110 Live cells can 
also be perturbed when exposed to lasers for long periods, influencing changes in their 
physiology.110 To manage these issues, parameters such as spectral range, step size, step 
number and bandwidth can be manipulated.107, 108 However, increasing scan speed, 
decreasing the number of spectral scans, or shortening the spectral range can produce a 
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less resolved spectrum and affect the quality of the resulting phasor plot.109 The ability to 
extrapolate important information and identify discrete microenvironments could be 
compromised without a fully resolved spectrum.  
Resolution is another crucial factor to consider when acquiring spectral images, 
especially with live cell analysis. Spatial and spectral resolution are both directly impacted 
by minimising laser exposure time.102, 109 Spatial resolution is managed by numerical 
aperture and magnification of the objective as well as bit depth to be captured. In contrast, 
spectral resolution is controlled by manipulating the parameters of the xyλ scan. The 
calibration of parameters depends on the individual experiment and if the data acquired 
enables an interpretation within a given level of accuracy. 102, 109 
Spectral Phasor analysis is sensitive to small changes in spectral properties. There 
is a multitude of factors that can contribute to spectral shifts in fluorescent probes and 
cellular environments. For instance, spectral shifts in fluorescent probes can be 
influenced by polarity and pH, where cellular environments can be influenced by cell-cell 
and cell-environment interactions.104, 107, 108 These issues can be alleviated through 
selecting morphologically similar cells, forcing cell synchronisation, and scanning 




1.4 Aims  
While Spectral Phasor analysis has been applied to elucidate hyperspectral shifts 
in the local microenvironments of individual fluorescent probes, it has yet to be applied 
to the characterisation of actin probe microenvironments.105, 107, 108, 109 The diversity of 
available actin probes reflects their numerous properties such as size, binding domain, 
target actin structure, and probe structure.65 As Spectral Phasor analysis has been shown 
to detect shifts in the local microenvironments of fluorescent probes, it is a tool that can 
potentially characterise actin probe microenvironments further based on their size, 
structure, or binding domain. Therefore, the development of a fixed cell model to further 
investigate the application of the Spectral Phasor approach is expected to reveal 
characteristic spectral properties associated with actin probe microenvironments within 
actin filaments.  
➢ To determine the applicability of Spectral Phasor analysis to characterise the 
microenvironments of actin probes, ActinGreen and ACTA1-488, bound to 
actin in fixed cells. 
➢ To determine if Spectral Phasor analysis can detect shifts in the spectral 
characteristics of actin probe microenvironments in fixed cells when treated 
with the actin disrupting compound, Latrunculin A. 
➢ To ascertain the ability of Spectral Phasor analysis to elucidate shifts in the 
spectral characteristics of actin probe microenvironments when localised in 





Chapter 2  
Characterisation of Actin Probe Microenvironments using 
Spectral Phasor Analysis 
 
2.1 – Introduction 
Applying the Spectral Phasor approach to the actin probes, ActinGreen and ACTA1-
488, is expected to further demonstrate the capability to characterise microenvironments 
in cells. The application of this approach to characterise actin probe microenvironments 
has not, to the best of our knowledge, been reported in the literature and therefore 
requires further investigation. To address this, the Spectral Phasor approach will be 
applied to the probes, ActinGreen and ACTA1-488, in fixed L6 myoblasts and myotubes in 
the early stages of development.  
The probes selected for this study are phalloidin-based (ActinGreen) and 
antibody-based (ACTA1-488). Fluorescently labelled phalloidin binds to F-actin with high 
affinity and is currently the gold standard for labelling endogenous actin filaments in fixed 
samples.65 Binding of phalloidin is reported to occur at the interface of three actin 
subunits from both strands, thereby locking the subunits together and strengthening 
intra- and inter-strand contacts.79, 80 Additionally, it has been reported that at least 7 actin 
subunits are required for the successful binding of phalloidin to filamentous actin.11 The 
second probe, ACTA1-488, is a primary monoclonal antibody (IgG1 isotype) that 
recognises the alpha muscle actin isoform in both G- and F-actin conformations. Tsukada 
et al. used known differences in isoelectric point and amino acid sequence at the N-




isoforms of actin differ in amino acid sequence at the N-terminus it is likely that this is the 
target epitope for binding of the ACTA1 antibody. 
The ActinGreen and ACTA1-488 probes used in this study are both conjugated to 
the rhodamine derived fluorophore, Alexa 488. This fluorophore is highly photostable, 
insensitive to pH over the range of 4-10, and exhibits a high molar extinction coefficient 
typical of rhodamines.73 The excitation and emission maxima of Alexa 488 are 495/518 
nm, respectively. Although the probes selected are both conjugated to Alexa 488, they 
differ in ways such as size, binding targets, and fixation protocols. The phalloidin-based 
ActinGreen has a molecular weight of 1320 Da in contrast to the molecular weight of the 
ACTA1-488 antibody which is 150,000 Da (150kDa).79, 85 Additionally, ActinGreen is F-
actin specific and cannot discriminate different actin isoforms.65 Whereas the ACTA1-488 
antibody is isoform specific and stains both G- and F-actin.25 However, the ACTA1 isoform 
is not expressed in non-muscle cells and therefore, has not been used for comparison in 
the undifferentiated myoblasts in this study. Finally, ActinGreen requires the use of 
crosslinking fixatives such as formaldehyde to preserve the phalloidin binding site.65, 67 
Whereas the ACTA1-488 antibody requires precipitating fixatives such as methanol to 
preserve the epitope for binding to the specific isoform.65, 71 
Fluorophores can exhibit spectral shifts based on the local microenvironment, 
binding, and behaviour of the bound species.105,107,108,109 As a consequence of the 
different actin binding and fluorescence characteristics of the ActinGreen and ACTA1-
488 probes, the application of the Spectral Phasor approach is expected to be able to 






2.2.1 Cell Culture and Passage 
 This research uses the L6 cell line which are progenitor myoblast stem cells 
that were originally derived from rat thigh muscle.112 The L6 cells are an adherent cell line 
and have a spindle shaped morphology in their myoblastic state. These cells can be 
induced to differentiate to form myotubes by reducing the culture media serum content 
from 10% fetal bovine serum (FBS) to 2% FBS over 14 days.113 
For continuous culture, L6 cells are maintained in complete Dulbecco’s Modified 
Eagle Medium (DMEM) supplemented with Fetal Bovine Serum (FBS) and require 
passaging approximately every 2-3 days to replenish spent nutrients. Through passage, 
the L6 cells were detached from the surface of the culture flasks and aliquots of cell 
suspension were transferred into new flasks with fresh media. Each time the L6 cell 
culture exceeded 13 passages; a vial of low passage L6 cells were brought up from 
cryostorage. 
Passaging of L6 cells is as follows, when confluency was observed under the 
microscope (Olympus CKX41) the flasks containing the cells were aseptically transferred 
into the biological safety cabinet (BCSII) spent media was removed from the flasks and 
disposed of in a solution of 10% bleach. The adherent cells were then washed once with 
1mL of 1X Phosphate Buffered Saline (PBS). After washing, the PBS was discarded and 
500µL of 1X 0.5% Trypsin-Ethylenediaminetetraacetic Acid (Trypsin-EDTA) was added 
to the flasks to promote cell detachment. The flasks were then placed into an incubator at 
37ºC for 10 minutes. The flasks were observed to confirm cell detachment and 500µL of 
complete DMEM (10% FBS) was added to each flask to neutralise Trypsin-EDTA activity. 




and the flasks were observed again to check for single cell suspension. Fresh T-25 flasks 
were labelled with the date and passage number. Each flask received 5mL of complete 
DMEM (10% FBS) and 20-30µL of cell suspension depending on confluency. The flasks 
were then incubated at 37ºC and 5% CO2 and checked for 80% confluency after two to 
three days. 
2.2.2 Fluorodish Seeding  
During cell passage, fluorodishes were set up for experimentation or confocal 
imaging. The 35mm fluorodishes (World Precision Instruments) each received complete 
DMEM (2 mL) supplemented with 10% FBS and 5µL of L6 cell suspension from the 
passaged flasks. 
2.2.3 Differentiation of L6 Rat Myoblasts  
 After the fluorodishes were seeded, the cells were left for four hours before they 
were checked for cell adhesion. The complete DMEM (10% FBS) was then removed and 
the fluorodishes rinsed gently with 1mL of 1X PBS. Differentiation was induced through 
serum starvation in the L6 cells by adding 2mL of complete DMEM (2% FBS) back into 
the fluorodishes. The dishes were incubated at 37ºC and 5% CO2 for 14-17 days and 
were checked weekly for the morphology of myotube like arrangements or early stages 





2.2.4 Fixation Protocol for Phalloidin-Based Staining 
Prior to fixation, media was discarded and the dishes were washed once with 2mL 
of 1X PBS. First, 1mL of fixative solution (Formalin, 4%) was added to each dish and 
incubated at room temperature for 15 minutes. The fixative solution was discarded after 
this time had elapsed and the dishes were then washed gently with 2mL of 1X PBS three 
times over a duration of 5 minutes. The dishes then received 1mL of permeabilisation 
solution (Triton X-100, 0.4%) and were incubated at room temperature for 15 minutes. 
The permeabilisation solution was discarded after this time and the wash step was 
repeated as previously described. Then 1mL of the blocking solution (BSA, 3%) was added 
to the dishes and incubated for 20 minutes at room temperature. When this time had 
elapsed, the blocking solution was discarded and 1mL of 1X PBS was dispensed into each 
dish. The dishes were then transferred back to the BSCII for staining with ActinGreen 
(ThermoFisher, R37110). The dishes each received 10µL of ActinGreen and were 
transferred to the fridge to incubate for 30 minutes in the dark. After this time, the dishes 
were washed with 2mL of 1X PBS three times to remove excess stain. The dishes were 
then resuspended with 1mL of 1X PBS, wrapped in foil and stored at 4ºC in the fridge 




2.2.5 Fixation Protocol for Antibody-Based Staining 
Prior to fixation the fluorodishes were transferred to the fume hood where the 
media was discarded, and the dishes were washed once with 2mL of 1X PBS. First, 1mL of 
ice-cold fixative solution (Methanol, 100%) was added to each dish and they were then 
incubated on ice for 5 minutes. The fixative solution was discarded after this time elapsed 
and the dishes were then washed gently with 2mL of PBS once. The dishes then received 
1mL of permeabilisation solution (Triton X-100, 0.4%) and were incubated at room 
temperature for 15 minutes. The permeabilisation solution was discarded after this time 
and the dishes were then washed with 2mL of 1X PBS three times over a duration of 5 
minutes. Then 1mL of the blocking solution (BSA, 3%) was added to the dishes and 
incubated for 10 minutes at room temperature. When this time has elapsed, the blocking 
solution was discarded and 1mL of 1X PBS was dispensed into each dish. The dishes were 
then transferred back to the BSCII for staining with the ACTA1 antibody. The dishes each 
received 10µL of the ACTA1-488 antibody (30µg/mL) (ThermoFisher, #53-6496-82). The 
dishes were then wrapped in foil and stored at 4ºC in the fridge overnight. The next day 
the dishes would be rinsed with 2mL of 1X PBS three times to remove excess stain and be 
resuspended with 1mL of 1X PBS for same day imaging. 
2.2.6 Spectral Data Acquisition 
 Project data was acquired using the Leica TCS SP5 inverted confocal microscope 
located at the Confocal Bio-Imaging Facility on Hawkesbury Campus. To view the 
samples the 63.0x1.20 UV water objective was used in conjunction with the 488 Argon 
laser (50% power). Spectral data was acquired by xyλ scan at a resolution of 256x256 
pixels and bit depth of 12-bit, across a detection range of 495nm – 629nm with a 
bandwidth of 9.7nm at a scan speed of 150 Hz. This resulted in a 32-step acquisition 




2.2.7 Spectral Phasor Analysis  
Spectral Phasor analysis was performed using the SimFCS 4 software package 
(version 12/05/2018), developed by Enrico Gratton.114 All XYλ data obtained from the 
confocal microscope was imported into SimFCS 4 and “referenced” and “read” 
(Appendix A2.1 and A2.2). The phasor plot was calibrated with a start and end 
wavelength of 495 and 629 nm, respectively. Cells of interest were masked to remove 
background interference (Appendix A3.1 and A4.1). User defined cursors (size 0.015) 
were placed onto the phasor plot to generate λmax and width values which were 
recorded in Microsoft Excel. The data was subsequently moved into GraphPad Prism 8 
for generation of statistical analysis and graphical representation. Statistical analysis 
was performed using Ordinary one-way ANOVA, Brown-Forsythe and Welch ANOVA, 






2.3.1 Spectral Phasor Analysis reveals characteristic actin probe 
microenvironments  
 A comparison of spectral shifts between ActinGreen (phalloidin) and ACTA1-488 
(antibody) in filaments and nuclear regions was performed on fixed undifferentiated L6 
myoblasts and myotubes in the early stages of development. These sets of cells also serve 
as the controls for comparison with treated cells in following sections.  First, the spectral 
profiles of ActinGreen and ACTA1-488 associated with filaments and nuclear regions 
were analysed within each cell type. 
Cursor (0.015) analysis was used to isolate the spectral profiles of ActinGreen 
associated with filaments and nuclear regions in undifferentiated myoblasts (Figure 2.1).  
The mean λmax and width values for filament associated ActinGreen are 527.0 ± 0.1 nm 
(n= 81) and 13.5 ± 0.3 nm (n= 81), respectively. The mean λmax and width values for 
nuclear associated ActinGreen are 526.2 ± 0.4 nm (n= 54) and 35.8 ± 2.1 nm (n= 54), 
respectively. There are statistically significant shifts in the λmax and width values between 
the filament and nuclear regions. There is a decrease in λmax of 0.8 nm (p= 0.0112) and an 
increase in width of 22.4 nm (p= <0.0001) in the nuclear region. The spectral profiles of 
ActinGreen associated filament and nuclear regions were isolated via cursor (0.015) 
analysis in early stage myotubes (Figure 2.2). The mean λmax and width values for filament 
associated ActinGreen are 526.5 ± 0.1 nm (n= 81) and 14.4 ± 0.3 nm (n= 81), respectively. 
The mean λmax and width values for nuclear associated ActinGreen is 525.6 ± 0.3 nm (n= 
54) and 35.2 ± 1.8 nm (n= 54), respectively. There are statistically significant shifts in the 
λmax and width values between the filament and nuclear regions. In the nuclear region, 




<0.0001). Next, the spectral profiles of ACTA1-488 associated filament and nuclear 
regions were isolated by cursor (0.0015) analysis in early stage myotubes (Figure 2.3). 
The mean λmax and width values for filament associated ACTA1-488 are 525.8 ± 0.1 nm 
(n= 81) and 12.8 ± 0.3 (n= 81), respectively. The mean λmax and width values for nuclear 
associated ACTA1-488 are 525.2 ± 0.2 nm (n=54) and 23.9 ± 0.9 nm (n= 54), respectively. 
There are statistically significant shifts in the λmax and width values between the filament 
and nuclear regions. There is a decrease in λmax of 0.6 nm (p= 0.0160) and an increase in 
width of 11.2 nm (p= <0.0001) in the nuclear region.  
Overall, ActinGreen in early stage myotubes exhibited a greater statistically 
significant shift in mean λmax values between the filament and nuclear regions in 
comparison to ActinGreen in undifferentiated myoblasts and ACTA1-488 in early stage 
myotubes when observed individually. Moreover, shifts in mean width values are of 








2.3.2 Comparison of ActinGreen and ACTA1-488 microenvironments 
The spectral profiles of ActinGreen and ACTA1-488 associated filament and 
nuclear regions were compared against one another in undifferentiated myoblasts and 
early stage myotubes. When comparing ActinGreen associated filament and nuclear 
regions between undifferentiated myoblasts and early stage myotubes, there was a 
statistically significant difference in the mean λmax of the filaments (Figures 2.4 and 2.5). 
The mean λmax of the filaments was 527.0 ± 0.1 nm (n= 81) and 526.5 ± 0.1 nm (n= 81) for 
ActinGreen in myoblasts and early stage myotubes, respectively. There is a decrease in 
λmax of 0.5 nm (p= 0.0245) in ActinGreen associated filaments in early stage myotubes. 
There were no other significant shifts in spectral profiles between ActinGreen associated 
filament and nuclear regions between these cell types. The spectral profiles of ActinGreen 
and ACTA1-488 associated filament and nuclear regions were compared against one 
another in early stage myotubes. Statistically significant shifts were observed in the mean 
λmax of filaments and width values of filaments and nuclear regions (Figures 2.4 and 2.6). 
The mean λmax of filaments was 526.5 ± 0.1 nm (n= 81) and 525.8 ± 0.1 nm (n= 81) for 
ActinGreen and ACTA1-488, respectively. There is a decrease in mean λmax of 0.7 nm (p= 
0.0007) in ACTA1-488 associated filaments. The mean width of filaments was 14.4 ± 0.3 
nm (n= 81) and 12.8 ± 0.3 nm (n= 81) for ActinGreen and ACTA1-488, respectively. There 
is a decrease in mean width of 1.6 nm (p= 0.0002) in ACTA1-488 associated filaments. 
The mean width of the nuclear regions was 35.1 ± 1.7 nm (n= 54) and 23.9 ± 0.9 nm (n= 
54) for ActinGreen and ACTA1-488, respectively. There is a decrease in the mean width 
of 11.2 nm (p= <0.0001) in ACTA1-488 associated nuclear region.  
First, the spectral profiles of ActinGreen associated with filament and nuclear 
regions were compared in undifferentiated myoblasts and early stage myotubes. Only one 




ActinGreen when compared directly in different cell types. No significant shifts were 
observed in mean width values. Further, the spectral profiles of ActinGreen and ACTA1-
488 associated with filament and nuclear regions were compared in early stage myotubes. 
Only one statistically significant shift was observed in the mean λmax values in filaments 
when comparing ActinGreen and ACTA1-488 in the same cell type. Shifts were also 
observed in mean width values in both filament and nuclear regions, however the shift in 
width values associated with the nuclear region show greater statistical significance than 









2.4.1 ActinGreen and ACTA1-488 microenvironments 
The present study sought to determine the applicability of Spectral Phasor analysis to 
characterise two actin probes, ActinGreen and ACTA1-488, in myoblasts and myotubes in 
the early stages of development. To achieve this, comparisons of ActinGreen and ACTA1-
488 microenvironments at filaments and nuclei of fixed myoblasts and early stage 
myotubes was performed using the Spectral Phasor approach. First, the spectral 
properties of filament and nuclei associated ActinGreen and ACTA1-488 in myoblasts and 
early stage myotubes were compared independently (Figures 2.1, 2.2, and 2.3). Secondly, 
the spectral properties of filament and nuclei associated ActinGreen and ACTA1-488 in 
myoblasts and early stage myotubes were compared directly (Figures 2.4, 2.5, and 2.6). It 
was revealed that ActinGreen and ACTA1-488 microenvironments in filaments and nuclei 
have distinct spectral properties when these regions are compared both independently 
and directly in myoblasts and early stage myotubes.  
Emission spectrums are indicative of the local microenvironment of a fluorophore, 
comparisons of these emission spectra in an image can lead to a greater understanding of 
the molecular environment of the target molecule to which the fluorophore is bound. 
Individual wavelengths are indicative of specific molecular environments. Therefore, 
shifts in λmax are indicative of the actin-bound probes experiencing changes in their local 
microenvironment. For example, Yengo et al. produced a study observing molecular 
interactions of actin-binding sites of myosin. A 10 nm blue shift in the peak emission 
wavelength of 546-MDE was reported upon actin binding and revealed the myosin 
residue Trp-546 exists in a buried environment.115 This was evidence of specific 




myosin. In conjunction with λmax, spectral width data is also collected and analysed from 
emission spectra and is suggestive of the degree of heterogeneity in cellular 
microenvironments. Sediqi et al. utilised the Spectral Phasor approach to detect emission 
changes of the sodium (Na+) probe, CoroNa Green, in Na+ microenvironments.116 The 
shifts in emission spectra of CoroNa Green both temporally and spatially in differentiating 
L6 myoblasts were analysed. The reported broadening and narrowing of spectral width 
reflect the heterogeneity of Na+ microenvironments within the biochemical landscape of 
the nucleus and cytoplasmic membrane.116 
ActinGreen and ACTA1-488 are both conjugated to the Alexa 488 fluorophore. 
However, ActinGreen is a phalloidin conjugate and ACTA1-488 is an antibody conjugate 
and there are inherent differences in their size, binding sites, and target actin 
conformations. When comparing the spectral properties of the probes between the 
filament and nuclear regions in myoblasts and early stage myotubes independently, 
increases in λmax and narrower spectral width were observed in ActinGreen and ACTA1-
488 microenvironments in filaments. This indicates that the probes are experiencing 
different microenvironments at the filaments and nuclei as well as a decrease in 
heterogeneity. When directly comparing the spectral properties of ActinGreen in 
myoblasts and early stage myotubes the only shift to note is the λmax between the 
filaments. Whereas, when directly comparing the spectral properties of ActinGreen and 
ACTA1-488 in early stage myotubes, there are shifts between λmax of filaments and width 
of both filaments and nuclei. The shift in λmax of the ActinGreen filaments in myoblasts and 
early stage myotubes as well as that of ACTA1-488 in early stage myotubes, shows that 
these probes exhibit specific spectral properties when associated with filamentous actin. 
The probe binding location on actin, in combination with their size, and different fixation 




requires a crosslinking fixative, and binds at the interface of three actin molecules in a 
filament. In contrast, ACTA1-488 is large (MW ~150,000 Da), requires a precipitating 
fixative and binds to the N-terminus of actin molecules. It is possible that the disparity in 
probe size could influence their spectral properties. Alexa 488 conjugated to phalloidin is 
spatially closer to the target protein due to the size of the probe. Whereas the Alexa 488 
conjugate of the ACTA1 antibody would be spatially more distant from the target molecule 
and perhaps more sensitive to molecular interactions by a wider range of molecules. 
When considering the differences in fixation protocols and the impact fixatives have on 
the native architecture of cellular environments, cautious interpretation is recommended. 
In future works, a range of fixation protocols should be trailed and compared for each 
probe to ascertain the degree to which fixation influences the spectral properties of the 
probe microenvironments. The cells analysed and discussed in sections 2.3.1 and 2.4.1, 
respectively, serve as controls for the following experiments. 
2.5 Conclusion 
The data presented here confirm that the Spectral Phasor approach can be 
successfully applied to ActinGreen and ACTA1-488 to characterise their spectral 
characteristics in different microenvironments. Spectral shifts were observed in both λmax 
and width based on the location of bound ActinGreen and ACTA1-488 microenvironments 
in filament and nuclei regions in L6 myoblasts and early stage myotubes. Further research 
may investigate the effects of an actin disrupting compound on the spectral properties of 






Chapter 3  
Spectral Phasor Analysis of Actin Probe Microenvironments 




In the previous chapter it was revealed that the actin probes, ActinGreen and 
ACTA1-488, have characteristic spectral properties when bound to filaments and nuclei 
in L6 myoblasts and myotubes in the early stages of development. The cells analysed in 
section 2.2.1 will serve as controls for the following work.  
The actin disrupting compound, Latrunculin A (Lat-A), is reported to be a potent 
inhibitor of actin activity by impacting actin polymerisation, filament distribution, and 
cellular morphology.54 Lat-A has a high affinity for G-actin and is reported to sequester it 
in a 1:1 stoichiometric ratio.55, 56 The binding site of Lat-A resides within the nucleotide 
binding cleft of actin and it is suggested that due to extensive interactions within the 
binding cleft, that actin is locked into the monomeric conformation.55-58 Although Lat-A 
preferentially binds to G-actin, it is reported to also affect actin filaments through 
depolymerisation and severing events. 57, 60 The further development of the Spectral 
Phasor approach may be useful in further elucidating the differential effects of Lat-A on 
actin dynamics.  Therefore, this chapter aims to investigate if the Spectral Phasor 
approach can detect shifts in the spectral characteristics of the microenvironments of 






3.2.1 Cell Culture and Passage 
Cell culture and passage was performed as described in section 2.2.1. 
3.2.2 Fluorodish Seeding 
Fluorodish seeding was performed as described in section 2.2.2. 
3.2.3 Differentiation of L6 Rat Myoblasts 
Differentiation of L6 cells was performed as described in section 2.2.3. 
3.2.4 Latrunculin A Treatment  
Latrunculin A (Sigma L5163) was reconstituted in DMSO to a concentration of 
100µg/mL. Using the stock solution, the final concentrations 120 nM and 25 nM were 
made up in 1X PBS to a final volume of 1mL. Fluorodishes that had undergone serum 
starvation containing myotube like cells were divided into groups, one for each 
concentration. Each fluorodish received treatment with LatA in the concentrations 
120 nM or 25 nM (10µL). The dishes were then exposed to the treatment for two different 
periods of time: 10 minutes and 2 hours. After these exposure times, the dishes 
underwent fixation with either the phalloidin or antibody protocols. 
3.2.5 Fixation Protocol for ActinGreen Staining 
 The fixation protocol for ActinGreen staining was performed as described in 
section 2.2.4. 
3.2.6 Fixation Protocol for Antibody-Based Staining 
 The fixation protocol for ACTA1-488 antibody staining was performed as 





3.2.7 Spectral Data Acquisition 
 The acquisition of spectral data was performed as described in section 2.2.6. 
3.2.8 Spectral Phasor Analysis 






3.3.1 Spectral shifts in ActinGreen microenvironments when treated with 
Latrunculin A 
Myotubes in the early stages of development were treated with Lat-A at 120 nM 
and 25 nM for time courses of 10 minutes and 2 hours before being stained with 
ActinGreen. Significant spectral shifts were observed when comparing actin probes at 
filament and nuclear regions within the treated cells. 
 Cursor (0.015) analysis was used to isolate spectral profiles of ActinGreen 
associated with filaments and nuclear regions in cells treated with Lat-A at 120 nM for 2 
hours (Figure 3.1). The mean λmax and width values for filament associated ActinGreen 
was 526.3 ± 0.3 nm (n= 54) and 16.0 ± 0.6 nm (n= 54). The mean λmax and width values 
for nuclear associated ActinGreen was 526.0 ± 0.3 nm (n= 36) and 38.8 ± 2.7 nm (n= 36). 
There is a statistically significant shift in the mean width values between the filament and 
nuclear regions (Figure 3.2). There was an increase in width from the filaments to the 
nuclear region of 22.7 nm (p= <0.0001).  
 Cursor (0.015) analysis was used to isolate spectral profiles of ActinGreen 
associated with filaments and nuclear regions in cells treated with Lat-A at 120 nM for 10 
minutes (Figure 3.1). The mean λmax and width values for filament associated ActinGreen 
was 526.3 ± 0.2 nm (n= 54) and 14.5 ± 0.5 nm (n= 54). The mean λmax and width values 
for nuclear associated ActinGreen was 525.6 ± 0.3 nm (n= 36) and 35.1 ± 3.3 nm (n= 36). 
There are statistically significant shifts in the mean λmax and width values between the 
filament and nuclear regions (Figure 3.2). There was a decrease in λmax from the filaments 





 Cursor (0.015) analysis was used to isolate spectral profiles of ActinGreen 
associated filament and nuclear regions in cells treated with Lat-A at 25 nM for 2 hours 
(Figure 3.1). The mean λmax and width values for filament associated ActinGreen was 
526.0 ± 0.2 nm (n= 54) and 16.7 ± 0.4 nm (n= 54). The mean λmax and width values for 
nuclear associated ActinGreen was 526.4 ± 0.3 nm (n= 36) and 44.6 ± 2.3 nm (n= 36). 
There is a statistically significant shift in the mean width values between the filament and 
nuclear regions (Figure 3.2). There was an increase in width from the filaments to the 
nuclear region of 27.8 nm (p= < 0.0001). 
 Cursor (0.015) analysis was used to isolate spectral profiles of ActinGreen 
associated filament and nuclear regions in cells treated with Lat-A at 25 nM for 10 minutes 
(Figure 3.1). The mean λmax and width values for filament associated ActinGreen was 
526.0 ± 0.2 nm (n= 54) and 13.5 ± 0.3 nm (n= 54). The mean λmax and width values for 
nuclear associated ActinGreen was 526.3 ± 0.1 nm (n= 36) and 27.6 ± 1.1 nm (n= 36). 
There is a statistically significant shift in the mean width values between the filament and 
nuclear regions (Figure 3.2). There was an increase in width from the filaments to the 
nuclear region of 14.1 nm (p= <0.0001). 
 Spectral properties of ActinGreen associated filament and nuclear regions were 
compared in early stage myotubes treated with Lat-A. All treatment groups have an 
equivalent statistically significant shift in mean width values from filament to nuclear 
regions. There is one significant shift in mean λmax value from filament to nuclear region 






3.3.2 Spectral shifts in ACTA1-488 microenvironments when treated with 
Latrunculin A 
Myotubes in the early stages of development were treated with Lat-A at 120 nM 
and 25 nM for 10 minutes and 2 hours before being stained with ACTA1-488. Significant 
spectral shifts were observed when comparing actin probes at filament and nuclear 
regions within the treated cells. 
 Cursor (0.0015) analysis was used to isolate the spectral profiles of ACTA1-488 
associated with filament and nuclear regions in cells treated with Lat-A at 120 nM for 2 
hours (Figure 3.3). The mean λmax and width values for filament associated ACTA1-488 
was 525.6 ± 0.2 nm (n= 54) and 16.6 ± 0.5 nm (n= 54). The mean λmax and width values 
for nuclear associated ACTA1-488 was 526.3 ± 0.4 nm (n= 36) and 42.5 ± 3.6 nm (n= 36). 
There is a statistically significant shift in the mean width values between the filament and 
nuclear regions (Figure 3.4). There was an increase in mean width from the filament to 
the nuclear region of 25.9 nm (p= <0.0001). 
Cursor (0.0015) analysis was used to isolate the spectral profiles of ACTA1-488 
associated with filament and nuclear regions in cells treated with Lat-A at 120 nM for 10 
minutes (Figure 3.3). The mean λmax and width values for filament associated ACTA1-488 
was 525.3 ± 0.2 nm (n= 54) and 17.9 ± 0.5 nm (n= 54). The mean λmax and width values 
for nuclear associated ACTA1-488 was 524.1 ± 0.5 nm (n= 36) and 41.4 ± 2.6 nm (n= 36). 
There are statistically significant shifts in the mean λmax and width values between the 
filament and nuclear regions (Figure 3.4). There was a decrease in mean λmax from the 
filament to the nuclear region of 1.2 nm (p= 0.0474) and an increase in mean width of 




 Cursor (0.015) analysis was used to isolate the spectral profiles of ACTA1-488 
associated with filament and nuclear regions in cells treated with Lat-A at 25 nM for 2 
hours (Figure 3.3). The mean λmax and width values for filament associated ACTA1-488 
was 525.7 ± 0.2 nm (n= 54) and 15.8 ± 0.4 nm (n= 54). The mean λmax and width values 
for nuclear associated ACTA1-488 was 524.2 ± 0.6 nm (n= 36) and 47.9 ± 3.1 nm (n= 36). 
There are statistically significant shifts in the mean λmax and width values between the 
filament and nuclear regions (Figure 3.4). There was a decrease in mean λmax from the 
filament to the nuclear region of 1.5 nm (p= 0.0230) and an increase in mean width of 
32.1 nm (p= <0.0001). 
 Cursor (0.015) analysis was used to isolate the spectral profiles of ACTA1-488 
associated with filament and nuclear regions in cells treated with Lat-A at 25 nM for 10 
minutes (Figure 3.3). The mean λmax and width values for filament associated ACTA1-488 
was 525.2 ± 0.2 nm (n= 54) and 15.2 ± 0.4 nm (n= 54). The mean λmax and width values 
for nuclear associated ACTA1-488 was 525.2 ± 0.5 nm (n= 36) and 36.8 ± 1.7 nm (n= 36). 
There is a statistically significant shift in the mean width values between the filament and 
nuclear regions (Figure 3.4). There was an increase in mean width from the filament to 
the nuclear region of 21.6 nm (p= <0.0001). 
 Spectral profiles of ACTA1-488 associated filament and nuclear regions were 
compared in cells treated with Lat-A. All treatment groups have an equivalent statistically 
significant shift in mean width values from filaments to nuclear regions. There are two 
shifts of equivalent significance in mean λmax values from filament to nuclear regions in 







3.3.3 Comparison spectral properties of ActinGreen in control and Latrunculin A 
treated cells 
As previously reported in section 3.3.2, cells were treated with Lat-A at 120 nM 
and 25 nM for time courses of 10 minutes and 2 hours before being fixed and stained with 
ActinGreen. The filament and nuclear regions of these treated cells were compared 
against the ActinGreen early stage myotube control cells reported on in 2.3.1.  
 When comparing the spectral profiles of ActinGreen in filament and nuclear-
associated regions of differentiated myotubes between control and treated groups, 
statistically significant shifts were observed in mean width values only (Figures 3.5 and 
3.6).  Myotubes treated with Lat-A at 25 nM for 2 hours had an increase in mean width 
value of 2.3 nm (p= <0.0001) in filaments and an increase in the mean width value of 9.4 
nm (p= 0.0162) in the nuclear region in comparison with the control cells. Myotubes 
treated with Lat-A (25 nM) for 10 minutes had a decrease in the mean width value of 7.6 
nm (p= 0.0051) in the nuclear region in comparison with the control cells. There were no 
statistically significant shifts to report in λmax values across the four treatment groups and 
no significant shifts in mean width values to report in Lat-A groups treated with 120 nM 
for both 2 hours and 10 minutes (Appendix A6.1 and A6.2). 
 Spectral profiles of ActinGreen microenvironments associated with filament and 
nuclear regions were compared in control and Lat-A treated cells. Shifts are observed in 
the mean width values between the control cells and cells treated with Lat-A at 25 nM for 
time courses of 10 minutes and 2 hours. The group treated with Lat-A at 25 nM for 2 hours 
showed statistically significant shifts in both filament and nuclear associated ActinGreen 
microenvironments when compared to the control group. The shift in mean width values 




are no shifts in mean λmax values in ActinGreen microenvironments associated with 






3.3.4 Comparison spectral properties of ACTA1-488 in control and Latrunculin A 
treated cells 
As previously reported in section 3.3.3, early stage myotubes were treated with 
Lat-A at 120 nM and 25 nM for time courses of 10 minutes and 2 hours before being fixed 
and stained with ACTA1-488. The filament and nuclear regions of these treated cells were 
compared against those of the ACTA1-488 control cells (reported on in section 2.3.1) 
 When comparing the spectral profiles of ACTA1-488 in the filament and nuclear-
associated regions of early stage myotubes between control and treated groups, 
statistically significant shifts were observed in mean width values only (Figures 3.7 and 
3.8). Cells treated with Lat-A at 120 nM for 2 hours had an increase in mean width value 
of 3.8 nm (p= <0.0001) in filaments and an increase of mean width of 18.5 nm (p= 0.0001) 
in the nuclear region in comparison to the control cells. The next group treated with Lat-
A at 120 nM for 10 minutes had an increase in mean width of 5.1 nm (p= <0.0001) for 
filaments and an increase in mean width of 17.4 nm (p= <0.0001) in the nuclear region in 
comparison to the control cells. The next group treated with Lat-A at 25 nM for 2 hours 
had an increase in mean width of 3.0 nm (p= <0.0001) for filaments and an increase in 
mean width of 23.9 nm (p= <0.0001) in the nuclear region in comparison to the control 
cells. The final group treated with Lat-A at 25 nM for 10 minutes had an increase in mean 
width of 2.4 nm (p= 0.0001) for filaments and an increase in mean width of 12.8 nm (p= 
<0.0001) in the nuclear region in comparison to the control cells. There were no 
statistically significant shifts to report for λmax values for all treatment groups when 






To summarise, spectral profiles of ACTA1-488 microenvironments associated with 
filament and nuclear regions were compared in control cells and cells treated with Lat-A. 
Spectral shifts are observed in the mean width values between the control group and 
groups treated with Lat-A. Groups treated with Lat-A at 120 nM for 10 minutes and 2 
hours, and 25 nM for 2 hours, showed equivalent statistically significant shifts in mean 
width values for ACTA1-488 microenvironments associated with filaments when 
compared to controls. Additionally, the group treated with Lat-A at 25 nM for 10 minutes 
also showed a shift in mean width value in filaments. However, this shift was less 
statistically significant. The groups treated with Lat-A at 25 nM for 10 minutes and 2 
hours, and 120 nM for 10 minutes, showed equivalent statistically significant shifts in the 
mean width values for ACTA1-488 associated nuclear regions when compared to the 
control group. Additionally, the group treated with Lat-A at 120 nM for 2 hours also 
showed a shift in mean width values in the nuclear region. However, this shift was less 
statistically significant. Another observation is that the shift in mean width values for 
ACTA1-488 associated filaments is less significant when treated with Lat-A at 25 nM for 
10 minutes. However, conversely, the shift in mean width value of the nuclear region is 
less significant when treated with Lat-A at 120 nM for 2 hours. There were no significant 







3.3.5 Comparison of spectral properties of ActinGreen and ACTA1-488 in 
Latrunculin A treated cells 
Spectral profiles of ActinGreen and ACTA1-488 microenvironments in early stage 
myotubes treated with Lat-A were compared against controls in previous sections (2.3.4, 
2.3.5). Here, the spectral profiles of ActinGreen and ACTA1-488 microenvironments are 
directly compared in the filament and nuclear regions of early stage myotubes treated 
with Lat-A.   
 When comparing the spectral profiles of ActinGreen and ACTA1-488 in filament 
and nuclear regions of Lat-A treated cells, statistically significant shifts are observed in 
mean λmax and width values. Cells treated with Lat-A at 120 nM for 10 minutes had a 
decrease in mean λmax of 1.1 nm (p= 0.0006) and an increase in mean width of 3.4 nm (p= 
<0.0001) in filaments between ActinGreen and ACTA1-488 (Figures 3.9 and 3.12). Only 
one significant shift was observed in cells treated with Lat-A at 25 nM for 2 hours with a 
decrease in mean λmax of 2.1 nm (p= 0.0140) in the nuclear region between ActinGreen 
and ACTA1-488 (Figures 3.10 and 3.12). Two significant shifts were observed in cells 
treated with Lat-A at 25 nM for 10 minutes with increases in mean width of 1.7 nm (p= 
0.0386) and 9.2 nm (p= 0.0002) in filament and nuclear regions, respectively, between 
ActinGreen and ACTA1-488 (Figures 3.11 and 3.12). There were no statistically significant 
shifts in the mean λmax and width values of cells treated with Lat-A at 120 nM for 2 hours 
when comparing the filament and nuclear regions associated with ActinGreen and 










3.4.1 Effects of Latrunculin A on ActinGreen microenvironments 
Spectral Phasor analysis of ActinGreen and ACTA1 microenvironments in 
filaments and nuclei of myoblasts and myotubes in the early stages of development 
revealed distinct spectral properties. In addition to this, we also sought to characterise 
these probes in the same regions when cells are treated with an actin disrupting 
compound, Latrunculin A. To achieve this, early stage myotubes were treated with Lat-A 
at differing concentrations and time courses before undergoing fixation and staining with 
ActinGreen. Shifts in spectral properties were revealed in ActinGreen microenvironments 
between filament and nuclei regions in cells when compared individually under all Lat-A 
treatment regimens. Shifts in spectral width are consistent with what was observed in 
untreated early stage myotubes, in that the spectral width of ActinGreen narrows in 
filaments and broadens in nuclei. However, when comparing the control and the Lat-A 
treated cells, shifts in spectral properties were only apparent in the groups treated with 
25 nM. Between the control and treated cells (Lat-A 25 nM for 2 hours) spectral width 
broadens when comparing filaments and nuclei. There is also one shift in emission width 
broadening between control and treated cells (Lat-A 25 nM for 10 minutes) when 
comparing the nuclei. Interestingly, a greater shift in the spectral width of ActinGreen at 
the nuclei when treated for 10 minutes was observed when compared to 2 hours. The 
group treated for 2 hours exhibited a strong shift in ActinGreen spectral width in 
filaments. Spectral width is an indicator of heterogeneity of microenvironments and 
fluorescence intensity. The narrowing and subsequent broadening of spectral width at 
different time courses in ActinGreen microenvironments in the nuclei are indicative of a 
change in heterogeneity, signalling shifts in molecular interactions. Lat-A is a potent 




assembly, polymerisation disruption, and filament severing.54, 56, 58, 60 When considering 
the described effects Lat-A has on actin, it could be suggested that within the first 10 
minutes of exposure the narrowing of spectral width at the nucleus could be a result of G-
actin sequestration and a reduction in local microenvironment heterogeneity as assembly 
of filaments is slowed.  After 2 hours of Lat-A exposure, the broadening shifts in spectral 
width of ActinGreen bound filaments and nuclei indicate an increase in of heterogeneity 
in these microenvironments. The rapid depolymerisation or filament severing could be 
reflected by a broadening of spectral width. It is likely that the effects of Lat-A at different 
concentrations and time courses in this cell type is dependent on the microenvironments. 
Future work should test the effects of Lat-A over a larger range of concentrations and time 
courses to further investigate the differential effects of Lat-A on ActinGreen 
microenvironments. 
3.4.2 Effects of Latrunculin A on ACTA1-488 microenvironments  
Spectral Phasor analysis of ACTA1-488 microenvironments in filaments and nuclei 
of early stage myotubes revealed distinct spectral profiles. In addition to this, we also 
sought to characterise the probe in the same regions when cells are treated with an actin 
disrupting compound, Latrunculin A. To achieve this, early stage myotubes were treated 
with Lat-A at different concentrations and time courses prior to undergoing fixation and 
staining with the ACTA1-488 antibody. Shifts in emission spectra were revealed in 
ACTA1-488 microenvironments between filaments and nuclei when compared 
individually under each Lat-A treatment regimen. The shifts in spectral width are 
consistent with what is observed in the control cells, in that the ACTA1-488 
microenvironments are narrow in filaments and broaden in nuclei. However, when 
comparing the control cells with the Lat-A treated cells, significant shifts in spectral 




a broadening of spectral width between the filament and nuclei regions in treated cells 
when compared to these regions in the controls. As previously stated, the broadening of 
spectral width is indicative of an increase in the heterogeneity of a microenvironment.116 
This could likely be explained by the binding and sequestration of ACTA1-488 bound G-
actin by Lat-A. The binding site of Lat-A within the nucleotide binding cleft is spatially 
close to the inferred binding site of ACTA1-488 at the N-terminus and this may reflect a 
change in the local microenvironment of the probe.57 As suggested in section 3.4.2, future 
works should test the effects of Lat-A over a larger range of time points and 
concentrations. 
3.4.3 Comparison of the effect of Latrunculin A on ActinGreen and ACTA1-488 
microenvironments 
Spectral Phasor analysis of ActinGreen and ACTA1-488 microenvironments in 
filament and nuclei regions of early stage myotubes treated with Lat-A treated revealed 
shifts in spectral properties when compared individually and against controls. We also 
compared the spectral properties of ActinGreen and ACTA1-488 microenvironments 
directly in filament and nuclei regions of Lat-A treated cells. To achieve this, cells were 
treated with Lat-A at different concentrations and time courses prior to undergoing 
fixation and staining with ActinGreen or the ACTA1-488 antibody. Shifts in spectral 
properties are revealed when ActinGreen and ACTA1-488 are compared directly in 
filaments and nuclei in Lat-A treated cells. Shifts in λmax were observed between 
ActinGreen and ACTA1-488 in filaments and nuclei of cells treated with Lat-A at 120 nM 
for 10 minutes and 25 nM for 2 hours, respectively. This difference in λmax could be 
indicative of the Lat A binding and the spatial positioning of the probes. For example, if 
ActinGreen binds at the interface actin subunits in a filament, the binding of Lat-A may 




conformational changes due to Lat-A binding. As ACTA1-488 can bind to both G- and F-
actin, the shift in λmax could be an indication of what actin conformation the probe is bound 
to. Shifts in spectral width are also observed between ActinGreen and ACTA1-488 in the 
filaments of Lat-A treatment groups of 120 nM for 10 minutes and 25 nM for 10 minutes, 
as well as in the nuclei of the treatment group 25 nM for 10 minutes. In all instances, 
ACTA1-488 emission width is broader than that of ActinGreen. As previously discussed, 
this may be a function of microenvironment heterogeneity, differences in probe size, and 
binding sites. ACTA1-488 labelled G-actin could also be indicated because of Lat-A’s 
reported high affinity for G-actin and its subsequent sequestering activities. 
In future works, obtaining spectral properties of ActinGreen and ACTA1-488 
bound to purified actin could be used as a reference point for comparisons. Although this 
would not reflect the spectral properties of actin in a cellular context, it could potentially 




 The data presented here confirm that the Spectral Phasor approach can detect 
shifts in the spectral characteristics of actin probe microenvironments when treated with 
Latrunculin A. Variations in heterogeneity of the filament and nuclei regions examined 
was observed in ActinGreen and ACTA1-488 microenvironments in both control and 
treated cells. Future research should further investigate the spectral characteristics of 




Chapter 4  
Spectral Phasor Analysis of Actin Probes in Cellular 
Microenvironments 
 
4.1 Introduction  
The Spectral Phasor approach has been applied previously by Braithwaite to 
characterise emission spectra of ActinGreen stained F-actin in intracellular regions of 
fixed L6 myoblasts.117 They reported distinctly different spectra in the wavelength range 
of cell spanning F-actin filaments between the sub-perinuclear and peripheral 
cytoplasmic regions. Braithwaite also briefly investigated the influence of stem cell 
differentiation on F-actin spectral properties.117 They identified slight differences in the 
spectral emissions of the ROIs in undifferentiated myoblasts and myoblasts induced to 
differentiate for 18 hours prior to fixation. It was reported that these shifts are indicative 
of a change in binding, environment, or the interactions of molecules associated with F-
actin in early differentiation.117 In previous chapters we have established that the two 
actin probes of interest, ACTA1-488 and ActinGreen, have discrete spectral properties. 
To add to this work, we are developing a fixed cell model to characterise actin 
probe microenvironments in myotubes during the early stages of development using 
Spectral Phasor analysis. A great deal is understood about actin in muscle cells due to 
their utilisation in a lot of early investigations into actin.1-5 The previous chapters 
revealed that the actin probes have characteristic spectral properties associated with 
their microenvironments when bound at filament and nuclei regions in both control and 




Phasor approach can successfully distinguish characteristic spectral profiles for 
ActinGreen and ACTA1-488 actin microenvironments localised at the plasma membrane, 
cytoplasm, and nuclear membrane regions in fixed early stage myotubes. This is followed 
by further comparison with Latrunculin A (Lat-A) treatment to determine if the effect of 
this actin disrupting compound influenced the spectral profiles of ActinGreen and 
ACTA1-488 in the regions of interest. 
4.2 Methods 
4.2.1 Cell Culture and Passage 
Cell culture and passage was performed as described in section 2.2.1. 
4.2.2 Fluorodish Seeding 
Fluorodish seeding was performed as described in section 2.2.2. 
4.2.3 Differentiation of L6 Rat Myoblasts 
Differentiation of L6 cells was performed as described in section 2.2.3. 
4.2.4 Latrunculin A Treatment 
Latrunculin A treatment was performed as described in section 3.2.4. 
4.2.5 Fixation Protocol for ActinGreen Staining 
Fixation for ActinGreen staining performed as described in section 2.2.4. 
4.2.6 Fixation Protocol for ACTA1-488 Staining  
Fixation for ACTA1-488 staining was performed as described in section 2.2.5. 
4.2.7 Spectral Data Acquisition 
The acquisition of spectral data was performed as described in section 2.2.6. 
4.2.8 Spectral Phasor Analysis 





4.3.1 ActinGreen and ACTA1-488 microenvironments reveal characteristic 
spectral profiles in the ROIs  
 Through Spectral Phasor analysis the spectral profiles of ActinGreen and ACTA1-
488 are observed and compared in three localised regions in fixed early stage myotubes. 
The regions of interest (ROI) were the plasma membrane, cytoplasm, and nuclear 
membrane regions. These sets of cells will serve as controls for comparison with treated 
cells in following sections. First, ActinGreen and ACTA1-488 emission profiles localised 
within the ROIs were characterised and each ROI was compared.  
 Cursor (0.002) analysis was applied to isolate the spectral profiles of ActinGreen 
in the ROIs of early stage myotubes. The spectral profiles in the ROIs were compared 
against one another to ascertain if there are shifts between the regions. The mean λmax 
and width values for ActinGreen at the plasma membrane region was 526.7 ± 0.2 nm (n= 
18) and 14.4 ± 0.6 nm (n= 18), respectively. The mean λmax and width values for the 
cytoplasmic region was 526.6 ± 0.2 nm (n= 18) and 20.4 ± 1.2 nm (n= 18), respectively. 
The mean λmax and width values for the nuclear membrane region was 526.2 ± 0.3 nm (n= 
18) and 26.0 ± 1.6 nm (n= 18), respectively. There are no statically significant shifts in 
mean λmax values between the ROIs (Appendix A7.1 and A7.3) However, there are 
statistically significant shifts in the mean width values between the ROIs (Figure 4.1). 
Between the plasma membrane and cytoplasmic regions, there is an increase in mean 
width of 6.1 nm (p= 0.0003). Between the cytoplasmic and nuclear membrane regions 
there is an increase in mean width of 5.6 nm (p= 0.0271). Between the plasma membrane 





 Cursor (0.002) analysis was applied to isolate the spectral profiles of the ACTA1-
488 associated actin in the ROIs of early stage myotubes. The spectral profiles in the ROIs 
were compared against one another to ascertain if there are shifts between the regions. 
The mean λmax and width values for ACTA1-488 in the plasma membrane regions was 
526.0 ± 0.1 nm (n= 18) and 11.7 ± 0.2 nm (n= 18), respectively. The mean λmax and width 
values for the cytoplasmic regions was 525.9 ± 0.2 nm (n= 18) and 15.3 ± 0.5 nm (n= 18), 
respectively. The mean λmax and width values for the nuclear membrane region was 525.8 
± 0.3 nm (n= 18) and 20.9 ± 0.7 nm (n= 18), respectively. There are no statistically 
significant shifts in the mean λmax values between the ROIs (Appendix A7.2 and A7.3). 
However, there are statistically significant shifts in the mean width values between the 
ROIs (Figure 4.2). Between the plasma membrane and cytoplasmic regions, there is an 
increase in mean width of 3.6 nm (p= <0.0001). Between the cytoplasmic and nuclear 
membrane regions, there is an increase in mean width of 5.7 nm (p= <0.0001). Between 
the plasma membrane and nuclear membrane regions, there is an increase in mean width 
of 9.3 nm (p= <0.0001). 
To summarise, ActinGreen in the ROIs show no significant changes in mean λmax 
values but does have significant shifts in mean width values. The shift of greatest 
significance is observed between the plasma membrane and nuclear membrane ROIs, 
followed by the shift between the plasma membrane and cytoplasmic ROIs, and finally 
the shift of smallest significance was observed between the cytoplasmic and nuclear 
membrane ROIs. ACTA1-488 in the ROIs also showed no significant shifts in mean λmax 
values. However, there are significant shifts observed in the mean width values between 
the ROIs. All comparisons of mean width values for ACTA1-488 between the ROIs are of 
equivalent statistical significance. When comparing the shifts in mean width values of 




the ROIs were of greater significance than those of ActinGreen, except for between the 
plasma membrane and nuclear membrane ROIs, where the shifts were of equivalent 






 Next the spectral profiles of ActinGreen and ACTA1-488 localised in the 
ROIs in early stage myotubes were compared directly (Figure 4.3 and 4.4). When 
comparing the plasma membrane region, there is a statistically significant shift in the 
mean λmax and width values (Figures 4.3 and 4.4). The mean λmax in the plasma membrane 
regions was 526.7 ± 0.2 nm (n= 18) and 526.0 ± 0.1 nm (n= 18) for ActinGreen and 
ACTA1-488, respectively. There is a difference in mean λmax of 0.7 nm (p= 0.0079) 
between the plasma membrane regions. There are no other statistically significant shifts 
in λmax values to report (Appendix A7.4 and A7.5).  The mean width in the plasma 
membrane regions was 14.4 ± 0.6 nm (n= 18) and 11.7 ± 0.2 nm (n= 18) for ActinGreen 
and ACTA1-488, respectively. There is a difference in mean width values of 2.7 nm (p= 
0.0007) between the plasma membrane regions. The mean width in the cytoplasmic 
regions was 20.4 ± 1.2 nm (n= 18) and 15.3 ± 0.5 nm (n= 18) for ActinGreen and ACTA1-
488, respectively. There is a difference in the mean width values of 5.2 nm (p= 0.0015) 
between the cytoplasmic regions. The mean width in the nuclear membrane regions was 
26.0 ± 1.6 nm (n= 18) and 20.9 ± 0.7 nm (n= 18) for ActinGreen and ACTA1-488, 
respectively. There is a difference in the mean width values of 5.1 nm (p= 0.0274) 
between the nuclear membrane regions. 
 When directly comparing ActinGreen and ACTA1-488 in the ROIs of early 
stage myotubes there is one significant shift in mean λmax values and significant shifts in 
all mean width values. The significant shift in mean λmax value is observed when the 
plasma membrane regions of ActinGreen and ACTA1-488 are directly compared. When 
observing the mean width values, the greatest statistically significant shift occurred 
when comparing the plasma membrane regions, followed by the comparison of 
cytoplasmic regions, and finally the nuclear membrane regions which has the shift of 






4.3.2 Shifts in ActinGreen spectral profiles when treated with Latrunculin A 
   Myotubes in the early stages of development were treated with Lat-A at 120 nM 
and 25 nM for time courses of 10 minutes and 2 hours. Here, shifts in spectral profiles of 
ActinGreen localised in the ROIs of cells treated with Lat-A are compared. 
 Cursor (0.002) analysis was applied to isolate the spectral profiles of ActinGreen 
in the ROIs of cells treated with Lat-A at 120 nM for 2 hours. There are no significant shifts 
in the mean λmax values of ActinGreen spectral profiles when comparing the ROIs 
(Appendix A7.6 and A7.7). However, there is a statistically significant shift when 
comparing the mean width values of ActinGreen in the plasma membrane and nuclear 
membrane regions (Figures 4.5 and 4.6). The mean width values are 14.8 ± 0.9 nm (n= 
12) and 27.1 ± 2.4 nm (n= 12) for plasma membrane and nuclear membrane regions, 
respectively. There is a difference in the mean width values of 12.3 nm (p= 0.0008) 
between the plasma membrane and nuclear membrane regions. 
 Cursor (0.002) analysis was applied to isolate the spectral profiles of ActinGreen 
in the ROIs of cells treated with Lat-A at 120 nM for 10 minutes. There are no significant 
shifts in the mean λmax values of ActinGreen spectral properties when comparing the ROIs. 
However, there is a statistically significant shift when comparing the mean width values 
of ActinGreen in the plasma membrane and nuclear membrane regions (Figures 4.5 and 
4.6). The mean width values are 14.3 ± 1.3 nm (n= 12) and 24.8 ± 3.1 nm (n= 12) for 
plasma membrane and nuclear membrane regions, respectively. There is a difference in 
the mean width values of 10.5 nm (p= 0.0211) between the plasma membrane and 





Cursor (0.002) analysis was applied to isolate the spectral profiles of ActinGreen 
in the ROIs of cells treated with Latrunculin A at 25 nM for 2 hours. There are no 
significant shifts in the mean λmax values of ActinGreen spectral profiles when comparing 
the ROIs. However, there is statistically significant shifts when comparing the mean width 
values of ActinGreen between ROIs (Figures 4.5 and 4.6). The mean width values are 15.9 
± 0.7 nm (n= 12), 21.4 ± 0.9 nm (n= 12), and 31.6 ± 2.3 nm (n= 12) for the plasma 
membrane, cytoplasmic, and nuclear membrane regions, respectively. Between the 
plasma membrane and cytoplasmic regions, there is a shift in the mean width values of 
5.5 nm (p= 0.0006). Between the cytoplasmic and nuclear membrane regions, there is a 
shift in the mean width values of 10.2 nm (p= 0.0026). Finally, between the plasma 
membrane and nuclear membrane regions, there is a shift in the mean width values of 
15.7 nm (p= <0.0001). 
Cursor (0.002) analysis was applied to isolate the spectral profiles of ActinGreen 
in the ROIs of cells treated with Lat-A at 25 nM for 10 minutes. There are no significant 
shifts in the mean λmax values of ActinGreen spectral profiles when comparing the ROIs. 
However, there are statistically significant shifts when comparing the mean width values 
of ActinGreen between ROIs (Figures 4.5 and 4.6). The mean width values are 12.8 ± 0.5 
nm (n= 12), 16.6 ± 0.9 nm (n= 12), and 20.9 ± 1.0 nm (n= 12) for the plasma membrane, 
cytoplasmic, and nuclear membrane regions, respectively. Between the plasma 
membrane and cytoplasmic regions, there is a shift in the mean width values of 3.8 nm 
(p= 0.0080). Between the cytoplasmic and nuclear membrane regions, there is a shift in 
the mean width values of 4.3 nm (p= 0.0020). Finally, between the plasma membrane and 





When comparing the spectral profiles of ActinGreen between ROIs in treated cells, 
there are no significant shifts in mean λmax values across all treatment groups (Appendix 
A7.6 and A7.7). However, there are significant shifts in the mean width values across all 
treatment groups. The groups treated with 120 nM of Lat-A each have a significant shift 
in mean width between the plasma membrane and nuclear membrane regions. The group 
treated with 120 nM for 2 hours has a statistically greater shift than the group treated for 
10 minutes at the same concentration. The groups treated with 25 nM of Lat-A each have 
a significant shift in the mean width values between all ROIs. The groups treated with 25 
nM for 10 minutes and 2 hours show a shift of equivalent statistical significance between 
the plasma membrane and nuclear membrane regions. Additionally, mean width values 
for the plasma membrane and cytoplasmic regions, and cytoplasmic and nuclear 
membrane regions for the group treated with 25 nM for 2 hours have greater statistically 






4.3.3 Shifts in ACTA1-488 spectral profiles when treated with Latrunculin A 
Early stage myotubes were treated with Lat-A at concentrations of 120 nM or 25 
nM and time courses of 10 minutes and 2 hours. Here, shifts in the spectral profiles of 
ACTA1-488 localised in the ROIs of Lat-A treated early stage myotubes are compared.  
 Cursor (0.002) analysis was applied to isolate spectral profiles of ACTA1-488 in 
the ROIs of cells with Lat-A at 120 nM for 2 hours. There are no significant shifts in the 
mean λmax values of the ACTA1-488 spectral profiles when comparing the ROIs. However, 
there are statistically significant shifts when comparing the mean width values between 
ROIs (Figures 4.7 and 4.8). The mean width values are 15.4 ± 0.9 nm (n=12), 21.9 ± 1.9 
nm (n= 12), and 30.6 ± 3.1 nm (n= 12), for the plasma membrane, cytoplasmic and nuclear 
membrane regions, respectively. Between the plasma membrane and cytoplasmic 
regions, there is a shift in the mean width of 6.5 nm (p= 0.02274). Finally, between the 
plasma membrane and nuclear membrane regions, there is a shift in the mean width of 
15.2 nm (p= 0.0012). There is no significant shift between the mean width values of the 
cytoplasmic and nuclear membrane regions. 
 Cursor (0.002) analysis was applied to isolate spectral profiles of ACTA1-488 in 
the ROIs of cells treated with Lat-A at 120 nM for 10 minutes. There are no significant 
shifts in the mean λmax values of the ACTA1-488 emission profiles when comparing the 
ROIs. However, there are statistically significant shifts when comparing the mean width 
values between ROIs (Figures 4.7 and 4.8). The mean width values are 18.3 ± 2.2 nm (n= 
12), 21.7 ± 0.9 nm (n= 12), and 28.8 ± 1.6 nm (n= 12), for the plasma membrane, 
cytoplasmic, and nuclear membrane regions, respectively. Between the cytoplasmic and 
nuclear membrane regions, there is a shift in the mean width values of 7.1 nm (p= 




a shift in the mean width values of 10.5 nm (p= 0.0031). There is no significant shift 
between the mean width values of the plasma membrane and cytoplasmic regions. 
 Cursor (0.002) analysis was applied to isolate spectral profiles of ACTA1-488 in 
the ROIs of cells treated with Lat-A at 25 nM for 2 hours. There are no significant shifts in 
the mean λmax values of the ACTA1-488 emission profiles when comparing the ROIs. 
However, there are statistically significant shifts when comparing the mean width values 
between ROIs (Figures 4.7 and 4.8). The mean width values are 14.9 ± 0.4 nm (n= 12), 
22.9 ± 1.5 nm (n= 12), and 28.9 ± 1.8 nm (n= 12), for the plasma membrane, cytoplasmic, 
and nuclear membrane regions, respectively. Between the plasma membrane and the 
cytoplasmic regions, there is a shift in the mean width values of 8.0 nm (p= 0.0007). 
Finally, between the plasma membrane and the nuclear membrane regions, there is a 
shift in the mean widths of 14.0 nm (p= <0.0001). There is no significant shift between 
the mean width values of the cytoplasmic and nuclear membrane regions. 
 Cursor (0.002) analysis was applied to isolate spectral profiles of ACTA1-488 in 
the ROIs of cells treated with Lat-A at 25 nM for 10 minutes. There are no significant shifts 
in the mean λmax values of the ACTA1-488 emission profiles when compare the ROIs. 
However, there are statistically significant shifts when comparing the mean width values 
between ROIs (Figures 4.7 and 4.8). The mean width values are 13.6 ± 0.5 nm (n= 12), 
19.4 ± 1.0 nm (n= 12), and 24.1 ± 1.4 nm (n= 12), for the plasma membrane, cytoplasmic, 
and nuclear membrane regions, respectively. Between the plasma membrane and 
cytoplasmic regions, there is a shift in the mean width values of 5.8 nm (p= 0.0002). 
Between the cytoplasmic and nuclear membrane regions, there is a shift in the mean 
width values of 4.7 nm (p= 0.0408). Finally, between the plasma membrane and nuclear 




 When comparing ACTA1-488 between ROIs in Lat-A treated cells, there are no 
significant shifts in the mean λmax values across all treatment groups (Appendix A7.8 and 
A7.9). However, there are significant shifts in the mean width values across all treatment 
groups. The groups treated with Lat-A at 120 nM each have a shift of equivalent statistical 
significance between the plasma membrane and nuclear membrane regions. The group 
treated for 2 hours has a shift between the plasma membrane and cytoplasmic regions, 
whereas the group treated for 10 minutes has no significant shift between these regions. 
The group treated for 10 minutes has a shift between the cytoplasmic and nuclear 
membrane regions, whereas the group treated for 2 hours has no significant shift 
between these regions. For the groups treated with Lat-A at 25 nM, each have a shift of 
equivalent statistical significance between the plasma membrane and cytoplasmic 
regions, and the plasma membrane and nuclear membrane regions. The group treated for 
10 minutes has a shift between the cytoplasmic and nuclear membrane regions, whereas 






4.3.4 Comparison of Spectral Properties of ActinGreen and ACTA1-488 in control 
and Latrunculin A treated cells. 
 As previously reported in section 3.3.3, early stage myotubes were treated with 
Lat-A at concentrations of 120 nM and 25 nM in time courses of 10 minutes and 2 hours 
before being fixed and stained. The ROIs of these treated cells were compared against 
those of the control cells (reported on in section 3.3.1). There are no significant shifts in 
mean λmax and width values observed between the ROIs of the ActinGreen in control and 
treated cells (Appendix A7.10 and A7.11). However, there are significant shifts in the 
mean width values of the observed between the ROIs of ACTA1-488 in control and treated 
cells. 
 Cursor (0.002) analysis was applied to isolate spectral profiles of ACTA1-488 in 
ROIs of control cells and cells treated with Lat-A at 120 nM for 2 hours. There is only one 
statistically significant shift when comparing the mean width values of ACTA1-488 in 
ROIs of control and treated cells (Figures 4.9 and 4.10). The mean width values are 11.7 
± 0.2 nm (n= 18) and 15.4 ± 0.9 nm (n= 12) for the plasma membrane regions of the 
control and treated cells, respectively. There is a difference in the mean width values of 
3.7 nm (p= 0.0231). There were no significant shifts observed in the mean width values 
when comparing the cytoplasmic and nuclear membrane regions of control and treated 
cells. 
 Cursor (0.002) analysis was applied to isolate spectral profiles of ACTA1-488 in 
ROIs of control cells and cells treated with Lat-A at 120 nM for 10 minutes. There are 
statistically significant shifts in the mean width values of ACTA1-488 in ROIs of control 
and treated cells (Figures 4.9 and 4.10). For the cytoplasmic regions, the mean width 
values are 15.4 ± 0.5 nm (n= 18) and 21.7 ± 0.9 nm (n= 12) for the control and treated 




For the nuclear membrane regions, the mean width values are 20.9 ± 0.7 nm (n= 18) and 
28.8 ± 1.6 nm (n= 12) for the control and treated cells, respectively. There is a difference 
in the mean width values of 7.9 nm (p= 0.0071). There are no significant shifts observed 
in the mean width values when comparing the plasma membrane regions of control and 
treated cells.  
 Cursor (0.002) analysis was applied to isolate spectral profiles of ACTA1-488 in 
ROIs of control cells and cells treated with Lat-A at 25 nM for 2 hours. There are 
statistically significant shifts in the mean width values of ACTA1-488 in ROIs of control 
and treated cells (Figures 4.9 and 4.10). For the plasma membrane regions, the mean 
width values are 11.7 ± 0.2 nm (n= 18) and 14.9 ± 0.4 nm (n= 12) for control and treated 
cells, respectively. There is a difference in the mean width values of 3.2 nm (p= <0.0001). 
For the cytoplasmic regions, the mean width values are 15.3 ± 0.5 nm (n= 18) and 22.9 ± 
1.5 nm (n= 12) for control and treated cells, respectively. There is a difference in the mean 
width values of 7.6 nm (p= 0.0045). For the nuclear membrane regions, the mean width 
values are 20.9 ± 0.7 nm (n= 18) and 28.9 ± 1.8 nm (n= 12) for control and treated cells, 
respectively. There is a difference in the mean width values of 8.0 nm (p= 0.0140). 
 Cursor (0.002) analysis was applied to isolate spectral profiles of ACTA1-488 in 
ROIs of control cells and cells treated with Lat-A at 25 nM for 10 minutes. There is only 
one statistically significant shift when comparing the mean width values of ACTA1-488 
in ROIs of control and treated cells (Figures 4.9 and 4.10). For the cytoplasmic regions, 
the mean width values are 15.3 ± 0.5 nm (n= 18) and 19.4 ± 1.0 nm (n= 12). There is a 
difference in the mean width values of 4.1 nm (p= 0.0243). There are no significant shifts 
observed in the mean width values when comparing the plasma membrane and nuclear 




When comparing ACTA1-488 in the ROIs between control and Lat-A treated cells, 
there are no significant shifts in the mean λmax values (Appendix A7.12). However, there 
are significant shifts in the mean width values of ACTA1-488 in the ROIs between the 
control and treated cells. When comparing the control group and the group treated with 
Lat-A at 120 nM for 2 hours, there is one significant difference in mean width when 
comparing the plasma membrane regions. When the group treated with Lat-A at 120 nM 
for 10 minutes is compared to the control group, there is significant differences between 
the cytoplasmic regions and nuclear membrane regions of the control and treated cells. 
The difference between the cytoplasmic region compared in control and treated cells 
(120 nM for 10 minutes) are of greater statistical significance than the difference between 
the compared nuclear membrane regions. When comparing the control group and the 
group treated with Lat-A at 25 nM for 2 hours, there are significant shifts between all 
ROIs when comparing the mean width of ACTA1-488 in control and treated cells. The 
difference between the plasma membrane regions has the greatest statistically significant 
difference, followed by the cytoplasmic regions and then the nuclear membrane regions. 
When the group treated with 25 nM of Lat-A for 10 minutes is compared to the control 







4.4.1 Spectral properties of ActinGreen and ACTA1-488 microenvironments in 
cellular regions 
 The present study sought to determine the applicability of Spectral Phasor 
analysis to elucidate shifts in spectral properties of ActinGreen and ACTA1-488 
microenvironments at the plasma membrane, cytoplasm, and nuclear membrane regions 
in early stage myotubes. To achieve this, Spectral Phasor analysis was performed to 
compare the spectral properties across the regions of interest (ROIs) in early stage 
myotubes fixed and stained with ActinGreen and ACTA1-488. After the comparison 
between ROIs individually, the spectral properties of ActinGreen and ACTA1-488 
microenvironments within the ROIs were compared directly. Distinct shifts in spectral 
profiles were identified for ActinGreen and ACTA1-488 microenvironments across the 
ROIs when compared individually (Figures 4.1 and 4.2). Furthermore, shifts in spectral 
profiles were also identified when ActinGreen and ACTA1-488 microenvironments in the 
ROIs were compared directly (Figures 4.3 and 4.4). When the spectral profiles of 
ActinGreen and ACTA1-488 microenvironments are observed individually across the 
ROIs the spectral width is narrowest at the membrane and broadens in the cytoplasm and 
nuclear membrane regions. When ActinGreen and ACTA1-488 microenvironments in the 
ROIs are compared directly, the spectral widths of ACTA1-488 microenvironments are 
narrower at each region than those of ActinGreen. 
Shifts in spectral width are indicative of the heterogeneity of cellular 
microenvironments and fluorescence intensity. The narrow spectral width at the plasma 
membrane and successive broadening of spectral width across the cytoplasm and nuclear 




microenvironments. Actin interacts with many cellular proteins in a vast number of 
processes. Narrow spectral width at the plasma membrane of the early stage myotubes 
could indicate that more actin is accumulated in that microenvironment. An extensive 
reorganisation of the actin cytoskeleton is required by myogenic cells both before and 
after fusion occurs.40 As myogenesis is not a strictly linear process, myotubes elongate at 
their ends while simultaneously fusing with myoblasts at the center of the fiber.42 The 
polymerisation of F-actin occurs at the sites of myoblast-myotube fusion and is 
dependent on the WASp protein which regulates the nucleation of actin via the Arp2/3 
complex.42-44 Alternatively, these structures may also be stress fibers that are associated 
with myotube formation. The narrow spectral width of actin localised at the plasma 
membrane could be indicative of this ongoing fusion process or stress fiber formation. 
Transitioning to the cytoplasm the spectral width broadens, indicating an increase in 
heterogeneity of the microenvironment and a decrease in fluorescence intensity. It has 
been indicated that actin filaments spanning cells facilitate intracellular molecular 
transport through the association with myosin motor proteins.46, 47, 48 Therefore, it could 
be inferred that the increase in heterogeneity in microenvironments of actin filaments in 
the cytoplasm could be a result of the molecular transport of organelle associated 
traffic.44, 46 At the nuclear membrane region the spectral width is broadest indicating that 
of the three ROIs, the nuclear membrane region has the highest degree of heterogeneity. 
Actin localised around the nuclear membrane region is reported to regulate nuclear 
morphology via an actin cap.49, 50 The central portion of these actin cap fibers are 
physically attached to the nucleus through the LINC complex, a linker of nucleoskeleton 
and cytoskeleton.51-53 Therefore, the physical connection between actin and the nuclear 
membrane as well as the density and proximity of cellular components such as the 




region. When the spectral profiles of ActinGreen and ACTA1-488 microenvironments 
were compared directly in the ROIs both exhibit a narrow spectral width at the plasma 
membrane and subsequent broadening when transitioning to the cytoplasm and nuclear 
membrane. Although, the spectral widths of the ACTA1-488 microenvironments were 
narrower than those of ActinGreen in each ROI. As discussed in previous chapters this 
could occur due to differences in fixation protocols, binding domains, their differing 
affinities for G- and F-actin, the size of the probe and how distant the fluorophore is 
spatially when the probe is bound actin. 
In future work, applying the Spectral Phasor approach to cells at different the 
stages of myoblast and myotube development would be useful. This would provide 
spectral profiles of actin in the ROIs for comparison at various stages of myotube 
development. Counter staining organelles and other actin associated proteins could also 
aid in determining potential shifts in actin spectral emission profiles upon binding or 
interaction. The cells analysed and discussed in sections 4.3.1 and 4.4.1, respectively, 
serve as controls for the following experiments. 
4.4.2 Spectral properties of ActinGreen microenvironments in cells treated with 
Latrunculin A 
We sought to elucidate shifts in the spectral emissions of ActinGreen 
microenvironments at the plasma membrane, cytoplasmic, and nuclear membrane 
regions in early stage myotubes treated with Lat-A. Early stage myotubes stained with 
ActinGreen were analysed and discussed in sections 4.3.1 and 4.4.1 serve as the controls 
for comparison. Cells were treated with Lat-A at different concentrations and time 
courses before being fixed and stained with ActinGreen. First, spectral profiles of 




This was followed by a direct comparison of the ActinGreen microenvironments in the 
ROIs of control and Lat-A treated cells. Shifts in spectral width were observed when 
comparing ActinGreen microenvironments across the ROIs of the Lat-A treated cells 
(Figures 4.5 and 4.6). However, when comparing the ActinGreen microenvironments in 
the ROIs directly between the control and Lat-A treated cells, there were no significant 
shifts in spectral properties observed. The shifts in spectral properties of ActinGreen 
observed across the ROIs of the Lat-A treated cells were consistent with what was 
reported in section 4.4.1. The spectral width is narrowest at the plasma membrane and 
gradually broadens transitioning through the cytoplasm to the nuclear membrane. 
Therefore, this is still indicative of an increase in the heterogeneity of these 
microenvironments. As no significant shifts were observed in the ActinGreen 
microenvironments in the ROIs between the control and Lat-A treated cells, it is likely 
that the action of Lat-A is not responsible for the significant shifts observed in spectral 
width between the ROIs in Lat-A treated cells when compared individually (Figure 4.6). 
One possible reason for this is that Lat-A is reported to have a higher affinity for G-actin 
and concentrations above the 200 nM range, are required to significantly alter actin 
filaments.60 The significant shifts observed are likely more indicative of the heterogeneity 
and differential processes of ActinGreen microenvironments between the cellular regions 
where they were compared. In future work, higher concentrations of Lat-A could be 





4.4.3 Spectral properties of ACTA1-488 microenvironments in cells treated with 
Latrunculin A 
Shifts in the spectral properties are observed in ACTA1-488 microenvironments 
at the plasma membrane, cytoplasmic, and nuclear membrane regions in early stage 
myotubes treated with Lat-A. Myotubes in the early stages of development stained with 
ACTA1-488 were analysed and discussed in sections 4.3.1 and 4.4.1 serve as controls for 
comparison. Here, cells were treated with Lat-A at different concentrations and time 
courses before being fixed and stained with the ACTA1-488 antibody. First, spectral 
profiles of ACTA1-488 microenvironments in the ROIs of the Lat-A treated cells were 
compared. This was followed by a direct comparison of the ACTA1-488 
microenvironments in the ROIs of control and Lat-A treated cells. Significant shifts in 
spectral width were observed when comparing the ACTA1-488 microenvironments 
across the ROIs of the Lat-A treated cells (Figures 4.7 and 4.8). Additionally, significant 
shifts in spectral width were observed in the ACTA1-488 actin localised in ROIs when 
compared directly between control and Lat-A treated cells (Figures 4.9 and 4.10). The 
shifts observed in ACTA1-488 microenvironments across the ROIs in Lat-A treated cells 
are consistent with those reported in sections 4.4.1. The spectral width is narrowest at 
the plasma membrane and gradually broadens when transitioning across the cytoplasm 
and to the nuclear membrane. This suggests an increase in the heterogeneity in these 
regions when moving from plasma membrane inward to the nuclear membrane. 
Interestingly, there are significant shifts in spectral width in ACTA1-488 
microenvironments between the control and Lat-A treated cells where there were none 
for ActinGreen microenvironments. Spectral width is observed to broaden with 
treatment when the regions are compared with those of the control cells. One possible 




lower affinity for F-actin. The ACTA1-488 antibody stains both G- and F-actin, therefore, 
it is feasible that the shifts in spectral width observed between the control and treated 
groups is a result of Lat-A binding and sequestration of G-actin. This may in turn increase 
the heterogeneity across the ROIs of Lat-A treated cells. The number of shifts observed 
when comparing the control and treated cells were greatest in the 25 nM for 2 hours 
group (each ROI), followed by 120 nM for 10 minutes (two ROIs). The treatment groups 
120 nM for 2 hours and 25 nM for 10 minutes each exhibited a shift in one ROI when 
compared to the controls. When comparing shifts in spectral width between 120 nM and 
25 nM when exposed for 10 minutes shifts are seen at the nuclear membrane for 120 nM 
and each exhibit shifts in the cytoplasm when compared with controls. The higher 
concentration (120 nM) of Lat-A could have penetrated the cell further and sequestered 
more G-actin in the 10-minute exposure than the lower concentration (25 nM). Thereby 
resulting in shifts at both the cytoplasmic and nuclear membrane regions. When 
considering the shifts in spectral width observed between the groups treated with 120 
nM and 25 nM when exposed for 2 hours, the lower concentration exhibits shifts at each 
ROI when compared with controls whereas the higher concentration exhibits a shift at 
the plasma membrane only. This may be indicative of the plasma membrane having a 
different microenvironment and an abundance of profilin and cofilin. In future work, as 
previously recommended it could be useful to test Lat-A in a range of concentrations over 
an increased number of time courses. This would be particularly interesting to test in a 









 The data presented here confirm that the Spectral Phasor approach can be applied 
to elucidate shifts in ActinGreen and ACTA1-488 microenvironments at the plasma 
membrane, cytoplasm, and nuclear membrane. Shifts in spectral width were observed 
across the ROIs of the controls and between the ROIs of the Lat-A treated cells. Shifts in 
the spectral width of ActinGreen microenvironments were observed between the ROIs in 
control and treated Lat-A treated cells, however, there were no significant shifts observed 
when directly comparing ActinGreen microenvironments between the ROIs of the control 
and Lat-A treated cells. The shifts observed in the ACTA1-488 microenvironments 
between the ROIs of the control and Lat-A treated cells could be due to the sequestration 
of G-actin by Lat-A which may in turn increase the heterogeneity in these regions. Future 
research may investigate Lat-A treatment over a broader range of concentrations and 
time courses in developing myotubes in order gain a better understanding the differential 
functions of Lat-A and how exposure time influences the spectral properties of actin 







 Final Conclusions 
 
The development of a cell model to further investigate the application of the 
Spectral Phasor approach was expected to reveal characteristic spectral properties 
associated with actin probe microenvironments in differentiating myotubes in the early 
stages of development. Here, Spectral Phasor analysis was applied to the actin probes, 
ActinGreen and ACTA1-488, to characterise their microenvironments when bound to 
actin in myotubes during the early stages of development. First, the probes were applied 
to cells to see if Spectral Phasor analysis could characterise distinct spectral properties 
of their microenvironments. 
Spectral Phasor analysis was used to characterise the microenvironments of the 
actin probes, ActinGreen and ACTA1-488, bound to actin in myotubes in the early stages 
of development after fixation. To achieve this, the spectral properties of ActinGreen and 
ACTA1-488 microenvironments were compared between filaments and nuclei in fixed 
cells. Spectral Phasor analysis showed that there were decreases in λmax and narrowing 
of spectral width in actin probe microenvironments associated with filaments. 
Additionally, when the actin probes were compared directly in filaments and nuclei, 
ACTA1-488 exhibited a decreased λmax and narrower spectral widths than ActinGreen. 
Therefore, this has shown that Spectral Phasor analysis has the capability and can be 






Since it was established that Spectral Phasor analysis can characterise distinct 
spectral properties of actin probe microenvironments, an actin disrupting compound was 
introduced to determine if there were detectable shift in the spectral properties of the 
actin probe microenvironments. The second aim addressed was to determine if Spectral 
Phasor analysis can detect shifts in the spectral characteristics of actin probe 
microenvironments in fixed cells after treatment with the actin disrupting compound, 
Latrunculin A. Myotubes in the early stages of development were treated with 
Latrunculin A at concentrations in the 20-120 nM range for short (minutes) and long 
(hours) periods of time prior to fixation. The spectral properties of ActinGreen and 
ACTA1-488 microenvironments were again compared between filaments and nuclei in 
the Lat-A treated cells. Spectral Phasor analysis showed that spectral shifts occurred in 
all treatment groups when the probe microenvironments were being individually 
compared between filaments and nuclei in the cells treated with Lat-A. Further, spectral 
shifts were also observed between the actin probe microenvironments in the control and 
Lat-A treated cells. The shifts associated with ACTA1-488 microenvironments showed 
broader spectral widths when compared with the control. This could be indicative of a 
change in the heterogeneity of the local microenvironment of ACTA1-488 that is likely 
associated with the activity of Lat-A. Finally, spectral shifts were also observed when 
ActinGreen and ACTA1-488 microenvironments were compared directly in treated cells. 
Again, the spectral properties of the ACTA1-488 microenvironments in treated cells 
exhibited broader spectral widths. This experiment has determined that Spectral Phasor 
analysis can detect shifts in the spectral characteristics of actin probe microenvironments 





It was determined that Spectral Phasor analysis is capable of characterising actin 
probe microenvironments and detecting shifts in their spectral properties after 
treatment with Latrunculin A in fixed cells. Therefore, we decided to apply Spectral 
Phasor analysis to the actin probe microenvironments in different cellular regions to 
elucidate possible shifts in their spectral characteristics. The final aim addressed was to 
ascertain the ability of Spectral Phasor analysis to elucidate shifts in the spectral 
characteristics of actin probe microenvironments when localised in different regions of a 
cell. The regions of interest were the plasma membrane, cytoplasm, and nuclear 
membrane of myotubes in the early stages of development. First, the spectral properties 
of the actin probe microenvironments were compared across the ROIs. Both ActinGreen 
and ACTA1-488 microenvironments exhibited their narrowest spectral widths at the 
plasma membrane and a broadening when transitioning to the cytoplasm and then the 
nuclear membrane where spectral width was broadest. This is indicative of the increasing 
heterogeneity of the cellular regions from the plasma membrane to the nuclear 
membrane and possibly reflects the involvement of actin in distinct cellular processes in 
these regions with its vast number of binding partners. When ActinGreen and ACTA1-488 
microenvironments in the ROIs were compared directly, the spectral width of ACTA1-
488 was narrower than that of ActinGreen in each ROI. Additionally, cells were again 
treated with the actin disrupting compound Latrunculin A in the regimens previously 
described, prior to fixation. The ActinGreen and ACTA1-488 microenvironments were 
again compared across the ROIs. Both ActinGreen and ACTA1-488 microenvironments 
still exhibit shifts in spectral width which is narrowest at the plasma membrane and 
broadest at the nuclear membrane.  




The work presented in this thesis demonstrates that Spectral Phasor analysis is a 
viable technique for the characterisation of actin probe microenvironments in a fixed cell 
model. Further, this work demonstrates the applicability of Spectral Phasor analysis to 
the elucidation of shifts in spectrally characterised actin probe microenvironments when 
perturbed by an actin disrupting compound and within different cellular regions. The 
Spectral Phasor approach represents a sensitive method for the analysis of distinct 
fluorescent probes, binding domains, cellular microenvironments, and effects an actin 
disrupting compound. 
When considering the outcomes of the work presented here, there are several 
investigations that may be considered in future work. To start, the degree to which 
fixation affects the spectral properties of actin probe microenvironments should be 
further explored. Given the degree to which different types of fixation affect native 
cellular architecture, a range of fixation protocols and fixatives should be compared in 
the context of the actin probe microenvironments. Next, it may be useful to apply Spectral 
Phasor analysis to the actin probes in purified actin to compile reference spectra. 
Although this would not reflect the spectral properties of actin in a cellular context, it may 
potentially aid in further identifying and characterising changing actin 
microenvironments. Further, applying the Spectral Phasor approach to cells at different 
stages of myoblast to myotube formation could further elucidate the nuances of actin 
microenvironments while serving as comparisons at various stages of differentiation. 
Further down the line Spectral Phasor analysis may be applied to actin probes in different 
muscle cell lines to ascertain if they exhibit spectrally similar properties or distinct 
spectral characteristics. Additionally, Spectral Phasor analysis could be further applied to 
study the differential effects of Latrunculin A on actin microenvironments in a range of 




the model developed in this thesis focuses on a cell line where the actin development 
processes are clearly defined by developmental timing and other cell types may respond 
more readily to stimuli.  Long term work could explore the application of Spectral Phasor 
analysis to elucidate characteristics of actin probe microenvironments in real-time and 
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Appendix 4 SimFCS 4 - Manual Selection using the Hand Draw Tool  
  
Figure A4.1 Manual selection using the hand draw tool in SimFCS 4 
To make a manual selection in SimFCS 4 double click on the reference cell image (A) to open another cell 
window (B). Right clicking on the newly generated cell image in B opens a menu and “Hand draw” is 
selected to open the window seen in (C). Clicking on the “Hand draw an enclosed area” button (blue box) 
in the “formflood” window (C) allows the user to trace around the area of interest with the mouse. Once 
the area of interest has been traced the “Click on area to fill” button (purple box) is pressed and the user 




Appendix 5 - SimFCS 4 – Applying a Manual Selection Mask 
  
Figure A5.1 Applying a manual selection mask in SimFCS 4 
To apply the manual selection mask to the reference cell image in window “1” tick the check box next to 





































   
Cursor Colour λmax (nm) Width (nm) 
120 nM / 2 hours  
Red 525.9 11.4 
Yellow 525.7 15.4 
Blue 524.4 19.7 
120 nM / 10 minutes  
Red 526.9 11.1 
Yellow 527.4 13.7 
Blue 527.4 15.9 
25 nM / 2 hours  
Red 526.4 15.2 
Yellow 527.3 18.7 
Blue 524.6 27.8 
25 nM / 10 minutes  
Red 526.4 12.4 
Yellow 525.5 15.8 
Blue 526.1 18.8 

































   
A4 B4 C4 D4 
Figure A7.8 Spectral comparison of ACTA1-488 in the ROIs of Latrunculin A treated cells. 
A-D1) Phasor plot. A-D2) Zoomed-in phasor plot displaying all cursors used to highlight ActinGreen isolated in plasma 
membrane (red), cytoplasm (yellow), and nuclear membrane (blue) regions. White arrows are used to show the 
cursors. A-D3) Reference spectral image, the red box indicates the region of the cell masked for analysis. A-D4) 


































Cursor Colour λmax (nm) Width (nm) 
120 nM / 2 hours  
Red 525.8 16.6 
Yellow 525.8 24.5 
Blue 527.9 34.8 
120 nM / 10 minutes  
Red 525.7 14.3 
Yellow 525.7 23.2 
Blue 527.4 28.1 
25 nM / 2 hours  
Red 525.4 15.1 
Yellow 527.3 30.2 
Blue 524.6 37.9 
25 nM / 10 minutes  
Red 525.8 13.2 
Yellow 526.3 18.6 
Blue 524.2 23.8 














   
Cursor Colour λmax (nm) Width (nm) 
Control  
Red 526.3 14.5 
Yellow 525.7 19.1 
Blue 524.2 24.1 
120 nM / 2 hours  
Red 526.0 13.5 
Yellow 526.4 16.8 
Blue 526.0 23.9 
120 nM / 10 minutes  
Red 526.7 13.5 
Yellow 526.6 16.3 
Blue 525.9 21.2 
25 nM / 2 hours  
Red 528.7 15.6 
Yellow 527.2 21.5 
Blue 526.3 33.8 
25 nM / 10 minutes  
Red 526.6 13.0 
Yellow 526.2 22.1 
Blue 524.7 26.2 
Table A7 λmax and spectral width values for each cursor shown in Figure A7.10 


